Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Thermoanaerobacter tengcongensis MB4, MB4

>TTE1401 predicted membrane-associated Zn-dependent protease 1
MTIILSIIVLSVLVMFHEFGHFIVAKLSGARVNEFSIGFGPRLFKKKYGE
TEYSFRALLFGGYVALEGEDEKSSDPRAIINKPWPVRLAVFAAGPLMNIL
LAFLLLFIVFFYIGSPVPKVQTVMEGYPAEKAGILPGDKILMINDIKINS
WEQLEKAISSSNGKTLVMEIERDNKIIKKEVTPVFDKKASKVMIGIVPAY
ERSFLLAVKTAVDRTIYFSKLIVLSLAMLISGKVSVNEIMGPVGIVQAVG
TVAKTGMINLLAFSALISVNLGLFNLLPFPALDGGRILFVLAEAVRGKPL
PPEKEGYIHYLGFLLLIALLIFATYRDIMRIF
>TTE1111 glucose-inhibited division protein
MNPESVEMLLKWNQKMNLAASTEEEKVVIKHFLDSLSLVRYNKIKRQEKV
IDTGTGAGFPGIPLKIVFPEIRLTLFLKHLRRKSIF
>TTE0406 hypothetical protein
MSKKRIIKIVLAVIMVIGAAFFLSYMIFYNPSYSYSEVYNKYYKNLKDID
LAKGLTTEQKLEDFEYLYNTLQKNYPFFEVGKRKTGFDWLSRKEEFEKRI
RETKNNIEFYNEIKRMVTLLQVAHARLVSPELFEMFKKALDMPITDGKMK
ELDPFQNPIIIKDYEYWKQNIKETTYILPIAFSYIEGKYVAIPYNKNESL
EGYGIPEGSILLKVNELTSDEYVKSLMDKTFLNYDFKRNKIVKYKLYVFA
DTLGDTIKLTFLSPKGEAIEKTLKPVELVINQSALDKMPLVKSILVKDKV
AYLKIPAMKISQKDIEKDGKEIYSFFKEIKNYPYLIIDIRGNGGGNLAYW
VENVVQPLIDKKIPYKAYTVVKNYDIKYTKTLDKLPKGKNYPPEVKDDFG
YFAEISYTVTPKNYVGFKGKIYLLTDAGVYSAAESFASFAKATKWATVVG
TPTSGGLGFNPDHLILPNSGLMVRYPNNMALNPDGTANEEVGTQPDIYVE
ESYDDFVNYLRDRKNIDENNILNMVKYDTVLKKVLEMTKLFIVK
>TTE2349 O-Glycosyl hydrolase family 30
MISKIKIALLLLLIIAFLFPSLYIRPVNASNDPVKVWFSSEYKPKDHGWY
TNNWESNITFKLSPQPDLFFTSPDEELLPTITVIPSIQYQTIEGIGTSLE
ESTIFNLSKMSSEVRSTVLRELFDRQNGIGLSLIRICFGSSDFTARDFYT
YDDLPKGNTDSELQYFTIQKDKDYNIISTLQGILQIDNNIKVFASPWSPP
AWMKSPETLIGGRLKSEWIPTLAKYYRKAIQAYQQEGIPIYAMTLQNEPL
YEPPDYPGCFVSPEQERDLAKALSRELKNNQLKTKLWIYDHTFFDWYAYI
TRWGLNAWSYVNTVFSDPEAYQAVDGVAFHDYGGEPSEMTRIRNTYPEKG
MYFTERSVWGIEGAARIIQYFRNWAKTYVAWVTMLDSNKQPEKWTFAPDP
TILIQNAQNPDYYWHTPEYYLLGQFSKFILPGAKRIYTNSGNPDALSNVA
FLNPDNTIVVVVVNATNSTQKFRILTSMGQIKTIIPAKTVATYKWKYEPT
IKDIISLRSRANNLFVSVEASENYYLKASQSQITLNTKFEVIPLDNGRIA
LKSIVNNKFVSAENAGSLPLVANRESIGNWEIFDVEILERENDIALKSLA
NNKYVCAENAGKDPLIANRDKVKGAWEAFELILANR
>TTE0668 predicted nucleoside-diphosphate sugar epimerases
MWKNKRKILLLLIDIILLNIAYFLAFYLRFDYNIPHQYFLLYKKTFYIVV
TVTVVTFIFFKQYNKIWRYASLHDIMDLIIFTTIGSAMAAFVLLFLQIHL
PRSIYPLYWFLSALLIGGSRIAYRSYMENSSKVKVKNIKYKKVLIVGAGD
AGRILVREIKNHPETGLKPVAIVDDDVSKLHRSIDDVPVVGKIDDIQEVI
TEKEIDEVIFAIPSAPRTVLKKVIDKCSEMRIKVKTLPAIYELVDGTISI
SSIRDVDINDLLGREPVKIDLEEISSYIKGKKVMVTGGGGSIGSELCRQI
ARFSPSRLIILDIYENNMYEVEQELKRKYPELDVICLVANIREEKKINKI
FSEYTPDIVFHAAAHKHVPLMEVSPHEAIKNNVYGTLNLVKVSDLYNVNR
FVMISTDKAVNPTSVMGASKRICEMIIQEYDKKSKTEFVAVRFGNVLGSN
GSVIPLFKKQIAEGGPVTVTHEEIKRYFMTIPEAVQLVIQAGAMAKGGEI
FVLDMGEPVKIIDLARTLIRLSGFEPDVDIPIKIIGLRPGEKLFEELLIS
DDKYVSTKHEKIFIEKPVSVDYGDLILTLEKYKDKIDDMDEDEIREFIKS
LVPEYNPDYQRSLMEEVAATEIE
>TTE2062 hypothetical protein
MKKYVIYALITVLALSLIGCGQTKKIETQKLQEIKEVKGSEVTVGSQKVN
LSDVVVAVGNSSDIKKGNKAYVISAGDKKYLVVYTGHKETKEKEGTEIID
TVKEAGNDGITLSNGKFYSATPNTTEQTIEDLKSIKKYNPDDFKAGDVVR
MLVKDDKIIAVVRY
>TTE2165 conserved hypothetical protein
MNLKRVLIFTIIFSLIVSLIVDFGRTRAENEYDTVEFVGDLKSLKDFASF
TGEDLKSILTKMKEAGMDGVAVNEVTLESLQQAGKISVSLLKDVENLYLL
SGNLGNLALEDYLKGLSTKDIEKYSNYIVVSTKNANTFKFLKEALTKRVS
PKDLIILSKGNDFAFIINKPKEVFVTKGLGFDENELFYIKSLGFDLIPRV
ENFTGIKDRDITEYVSILKKYGVRTVIFNGTDVLGNPEKISYAASLFKEN
GINVGIIDVPMGKKLQEGMSKFAKFTGYRGIKVYGLSEKETQKYDWEEIV
NKWFRGIIERNVRIIYVRAKIDDSKSHQYNIKENIAMIKDATDYIKRAGL
KVGIAKPLPEVHQGKFIEVLISLGVVAAGLLILELFGVSIRLLAILGIIG
VIGVSGILMSRFNDLGVKTVALAYSIVFPSLGIAYYVNRLDEFLKGKGEN
NFVWHALKIFFISLAISFAGALSIGAIMADSKYMLKIDYFRGVKFSFILP
LIFYVFYYIWRVYETHNFKAFWSKIKEFLDLDLKVWHVMAFVIAAVAGIL
YISRTGNEPIIKPTELELKFRDFLEHTLIARPRTKEFLIGDPALLIGLYT
VLKKFNGWAFVAGLLGSIGILSITNTFSHVESVLIIAIERTLFAWVLGAL
IGLIGIWLLSKILKNTKKEY
>TTE2348 O-Glycosyl hydrolase family 30
MKITGYVTARDYNIPFSKLEKIEKADTKRPDSFVKIYPDEELEEVIGFGG
ALTEAAAFNILSLPEEKQEKILKAYFDEKEGLGYKLVRIHMNSCDFSLES
YSCDDVEGDVELKHFNIERDKKWVIPLLKKIKRYVPDLKVLVSPWSPPAW
MKTNNDMKYGGKLKEEYKKTWAEFFVKFIKAYQEEGIDIWAVTVQNEPMA
VQIWESCIYTAEEERDFVKYYLGPTLLENGLSHIKILIWDHNKDIIYERV
KTILEDKEAAKYVWGVGFHWYAGDHFEQLKKIKEEFPHIKLVFTEGTQEG
GVNLGSWNLGERYAHEIIGDFNNYTIGFFDWNIVLDTMGGPNHVKNYCDA
PIIVDTEKKEIFYQSSYYYIGHFSKFIKPGSKTIKSEILDPRLEILSAKT
PEGKIIVVVMNKTEENIDILLDIGGDLYNAPSIKKSIETFVIN
>TTE0740 capsular polysaccharide biosynthesis
MEEEITLRELIEVLLKRKWLIFIITVSITLVAAVFSFFIVKPTYEASTTI
AVTDVTPATGFFGSNTTVIFSDKDSGIPIFQSDTIEKDISLLLSSLLRYP
DMSVDAFKEEVTNPVVLTNTIKQLKLDPKRYTLDNFKKQISVSVLNNTNL
IQVTVKENDPQLAAEIANSIAQNFRNYVIERNTKQTDKLMQTLLKLIDLQ
NEKIRKAQEDLVNFLNNASNKLEIEQKQKELSLLKNTRDIMLEKYNMLEL
VKESDLGKQSILITSKALVPEKPVAPKKMLNVLIAFILGGQNS
>TTE0735 capsular polysaccharide biosynthesis homolog ywqE
MIDIHCHILPNIDDGSSSMETSIEMARIALEDGIKFIIATPHYIEYEHEI
PREAILKNCQELNQFLIQKGIELKILPGAEVFISPTIVESYKKGKIISLN
DGRKYILIELPVAAYPEYTEDIIFEFKVMGITPIIAHIERYFYVKDDFEL
VFRLINKGALIQVNSTSVMGLFGKEVKNKSIDLIKHRLVHFIASDAHTTR
GRVPKISEALEILRKERVDESYIDYILINSQKVVRGEEIEILDPIKKKVK
WFYRLKRRF
>TTE1980 hypothetical protein
MYWVATFVISWVIFLSLIDLRYIKYTIWGGILAAIFQLTVDEIAITLNLY
SFSDPVFTVFKSSFFFTFGAPFCIGVLYAQTYPRKKNLQLANVFILTLLF
FIMEYSLHNAGALEYIKWSYIYSLIVDVGALLAVGNLINLFSLSPWMRRK
ENER
>TTE2366 hypothetical protein
MLNKLTNIRIDSACNSPSIKEHKSLLVFDFSLDIPSHQAEIHENTIKIIF
SSVPLNMPEGIYKVLDGIISFVEIKQQGEDIVACVHLDFPSNFEVKTIKG
IPSQFEVYIDRSPLIEVLKGRKIAINPGFSKKTKSPTGLLMHIPIMGIAK
KLNFLLSNCGAESKITWEKDPQEKNLKDLDCEILIDLYTELSSKKESGFK
VYYEDQNDASFKLAKHINKAMEEKLQLPNLGIFQKRFEYKESIIPVGIVP
AMEDVRIDDAHLRDVDYREKVAQAVFNGLIRFYS
>TTE1653 predicted S-adenosylmethionine-dependent methyltransferase involved in cell envelope biogenesis
MEYVHKSVLLKETIEHLNINPEGIYVDGTLGGGGHSEEILKRLTTGKLIA
IDRDEEAILAAKERLKDYKNVIYIKDNFKNIKEILRNLGIEKVDGILLDL
GVSSYQLEEVERGFSYMKDAPLDMRMDKTSPFSAYDVVNRYSEKELERVI
REYGEEKWASRIAKFIVEERKKGDIKTTSQLVEIIKKAIPASARRTGPHP
AKRTFQAIRIEVNEELKDLDRALEDMVEVLRGKGRIAVITFHSLEDRIVK
NTFKKLENPCTCPPGLPCTCGKQPVIKIITKKPILPSKEEVEENPRSRSA
KLRVAEKL
>TTE1528 putative peptidoglycan-binding domain-containing protein
MERQELGSRLLYEGLAGYDVLELQMILQSLGYDPGPIDGIFGPRTKKAVM
KFQRDNGLKVDGIVGPETMKVIRMLVP
>TTE1308 hypothetical protein
MEEVKWIVLISIPLIVTFAVKKFFRELLYHPYCLKENYKKKLIPVCGGIV
FVPSFFASIFLINLLGHSVEYQEVILIALSLISFVGFADDLIGDTKVKGL
KGHILRLIKGKPTTGSLKALGGLLIAAFVSYEIAGISLIEVTIDSLIIAL
FTNLLNLLDLRPGRCAKGFLLLSLLFLLIGRGKPEFLFILFVIVLVYLPE
DLKAQLMMGDTGSNVLGMASGIAAILLFNFYEKLILLFALILFHLFTEKY
SLTAIIEKNKFLNYLDMLGRKGEE
>TTE0900 hypothetical protein
MKRLYKYLLILLLIILQSSLFKFIDILGIKPDAVFIFVLSLSLLNGPWEA
VYLSLFAGLVQDVIFNNALGVSTFSLLVVSYITGLLSKNVFKESTFVAFV
FTFLGTLLYNLIIMFSMVLMKYQFNFLESLLDVGMIQSVYNSLIVAFVYR
YIVAFNRYVSENKKLFSRKSWF
>TTE2566 hypothetical protein
MWVLSGMAGIVVAYLLNSAVVKRYGERAVIYIVPFIEESSKTVFGYLTSS
ILASHFMFGIAEAVNDYTKASYKINGRAAVLSILSHSIFGVISYVLVEKV
NLFVAILSASLLHLLWNRFMLR
>TTE0840 conserved hypothetical protein
MFQKKSQVEINPEKIDTVIGKNTSFEGTIRSEGTLRIDGNFSGQIETKGN
VIIGEGAKIQANISSDNVIVSGEVKGNILAKSQLQITSTGKVYGDIEVQN
LVIEEGAVFEGKSKMSKSFPQEEDKKVEE
>TTE1303 sporulation protein IVB
MNKKLIKLVLFALLSFFLVFANYFTPIQELAKTPSNFKIFQGDKLSYNFK
FPFKITFEIDKEGLLRINGKDEITIEAVNTGKANLDVKLFGFLPLKHINV
DVVPTIKVVPGGQAIGVKLNTKGALVVGYSDIMGEDGKIYSPYKEGKIQI
GDIILEVNGVEIKQAEDITNIANKLQGKALKLKINRKNAILYTVIHPVKS
KEDKQYRIGLWVRDHTAGIGTLTFYYPSQKVYAALGHAITDIDTGHVLSV
ENGEIMNTRITSIDQGRRSKPGELKGVFFEEVDAIGNILKNTQFGIYGYM
YNDFKNEFYGEIPVAYQGQIKEGPAKILATIDNKGVQEFDVEIVKKVYQE
SPTPKGMIVRIVDKNLLAKTGGIIQGMSGSPIIQNGKLVGAITHVFVNDP
SKGYAVYAEWMINEVNNLLNDKQVFINE
>TTE0827 LysM domain
MKKVVAVILAFVMAFGVVSQAYAYTKVHVVSRGESLYLIATWYGSDLDSI
RQANNKWDNLIYPGEKLLVPIKEDSDHYNYLVDRYLIAKMIYAEARGESF
EGKVAVGAVILNRVKSGIFPNTVAGVIYQPYAFESVLNGEFFNHEPDLEA
FKAADAALAGWDPTGGALYFFNPATSTSWWIWTRPVTTVIGHHWFAR
>TTE2551 spore cortex-lytic enzyme prepeptide
MSFRVRFKVIIAILVVFTTAVFEYTAISMTKTAMSNLYWGNTGSDVAKVQ
ARLKAWGYYDGPVDGFFGVKTWLAVRKFQAYNGLAVTGIVDDDTKVALGF
TTTAQDLAAYRATSSAGISDDVYLLAMLINGEARGEPYIGKVAVGAVVMN
RVRDPRFPKTIPGVIFQPGAFSAVEDGQMWLPPTEESIKAAIDAVSGWDP
TGGALYYYNAARVTNYWIFTRPILTQIGRHIFAR
>TTE1419 conserved hypothetical protein
MNQVNLQPGQKIKIGLNEGKTMYSSQVQDVSKDGTLLVDTPVYSGHLVPI
RVGSIVQVIYFTKQGLFIFYAKVLNRFSGKLPLLEIMPISGVERLQRRKY
FRLEKVIPFTYRIRGEEEKEYKGVIQDISGGGLRCRVDKKLEIGTIIDCS
FTLDEEIQVSGKVVRYEESMEEGYEVGVCYVDIEERMREKIIRYIFEEQR
KIRQKGIE
>TTE2169 hypothetical protein
MKKRAFVLILLMLFLLASCSREEKKIRDPFESIKSKLSKMESYTAEATVE
LYHNKFDTSFTVFQFYSKGKFRLEVFEKEEQPDKIVVYDGKRSYVYFRKV
DQIFVAENEKEIPLFSMISSFAKNYFEAGGEIEKKVLDNSYLVTVPIPER
NVVMYKEEMIFSKKDLIPVELRIFDINNELFAKITYKDFQYNLKLQDDLF
SEGTIKESMR
>TTE1172 hypothetical protein
MEINTIDKLPIYDLLPAEVKESFMYYATTDIVKDFEKFSKYVEPVDFNGK
IFLIVSRTTYSTANIFAEFCKETGFATVIGERTRKGDGGWLMPGLMRLPN
SGLIVRFDGAMLINQDGTSYFETGSIPDIEIKMMPKNPFEKDEELKQKIL
QVIKSLENEEKGIK
>TTE0733 capsular polysaccharide biosynthesis homolog ywqC
MMEEELDLREVFLILRKRIKIILLITVLAMLVSGLISYYVLSPVYKASTS
LIISRTQNITINDQIQLQDIQTSRMLAATYSEIVKSRRVLQPVVTKLNLP
MSVEDLKGKIDVTSKDNTEIIEISVRDNNPERAAEIANAIASSFMDNIVK
IMKIDNVQVIDRAVPPTSKVSPKTSLNVVIAGVLGLMISIFLVFLLEYMD
RTVKTPDDIKKYLNLPVLGIIPEVKNK
>TTE0256 AcrA, Membrane-fusion protein
MKRKYAYVIVAILLIAGIATFYFLNKTKTSTSSQIPYVTVTRGNISMTIT
GTGNLTGDVRAITLKNGVVKKVYFNVGDSVKKGDLLYELEDDNLNNQLEQ
AKLNLDLATQQLNQDTKNYNSAVAKLSITSPVDGVVEILVKEGQDVTPGM
PVAVVNVNKSNGSEEGQPSGNSGTNVTAQVSGTVEKIYVSSGQNVRKGEV
LIKLSSSNISDAQIQSDKIKVMQAQNNYNQILKQIESLKIYSPIDGKILS
QNIKEGDVLGNFSSNAGNNNLNASYVQTGFVPVLDITQLSSYESQPDTAV
IVGNSGYIVNLSVDETDIKNIKIGQKVQLTTDDLPGKVFSGTVSQVSQLP
TIQNGVASYNVTIQVDPSEDLMLGMSMDVAITVAEKNDVLLLPIQAVQTL
GNRQYVILYTDDMKNQNLSDANANNMRNLFRNNIRFIETGIHNNNFVEIV
SGLQEGDRVLIPLNSSLANSNNRNPQGFNFMMRPQGGFNRNTERPSGSFQ
GGSFNRSWQNNSSSGGNNR
>TTE1200 AcrA2, Membrane-fusion protein
MENKKSIWIWIVVLIIVVASIYFISVKNKEAGSAVEVTVSKVEKGDLVSL
FSTSGVVESKSKQEFYIFSPTKVLKVYVSVGDQVKKGDRLLELETQDLSI
QYQIAKKQLEMAQIQLEALKNLKQKQTEQSQIPTPSLPQQAPASEQSIPH
QTQAQFQQPTSSLSLDDQIKLQEKQVEIAELNLKSIQQNMNKMQKYVTAD
FDGTVTSLNAKENNYFTSTQFPAITVEDLQNLQVVLDVNPYDAVNLSEGQ
QAYIHFAGKTFEGKVNKISPTAVKVMSQTGGDSVVKVYVDILNNDGTIKP
GFKVDVDIKIGEKKDIIKIPSESIVTDKNGNEFVYVVENGIAKQRKVKTG
LTSDLETEILEGVNVGDKVILNPSAAIKDGVKVMTKGGKE
>TTE1601 AcrA3, Membrane-fusion protein
MRRNIIKILAFMVILAYAGKSVVSVYTEKKDTATVTYGNVILGFNTKAYI
IKDEMIIKAPFDGRVEKLVKEGERVSKGRAILEIYSSSFDEEKLRQLEAV
ESELKKQDTNIPFYKDLQKIDEMIKKEQDNYKEALKKDAELAKKILRRID
SLKAKKEEILKKGPLVLQNIESLKEQKEYLEKYISDNTVTINSPEAGIIS
YTFEGVEDILNTKNMFDLKIPKLSNLVFENKEVSGEVKEGQPVVKIVDNF
DWYLAVILEDKQASLLKEESGIKILFSDYPNEMRGRVIKVYKGDDKLYVG
IIKMIDEYPDFYKKSKADVEIKLKECWGLKIPVSAIAVENGKEGVWVLKN
GTSKPVFKEIEIEISDGSYAIVKGLKIYDRVLLQKERNRGD
>TTE1207 Alr, Alanine racemase
MKFDGVRPTRVEVYLDAITHNFREIKKIVGKNVKIMAVIKGDAYGHGASY
VAKFLEKEGVDYFGVATTEEALELREKGIKTPILIFGYTPPTQLRQIVKH
DLTQTVYDIKYAKELEKESLKQNKRAKVHIKIDTGLGRIGYIDFDLAQKE
ILEMANMRGLILEGIYSHFAAASEDDRDYCKEQFDKFMNLISSLEKKRLK
IPLKHIANAAAILNLNYSHLDMVRPGIILFGAYPSKRVERKVELRETLRF
TTRVVHLKDVPAGFFIGYGKSFVTKRKSVIATIPVGYADGLDRRLSNNYK
LLLKGKYVPIVGRVCMDQCMIDVTDVEGVEIGDEVVIIGTQNNETVSVES
MADKIETIPQEVFSRISRRVPRVYFYDGIKIGEVNYLK
>TTE2168 Alr2, Alanine racemase
MFDEIRPTRVEVNLDSIVHNFREIKRVVGDRVKVMGVVKANAYGHGAYHV
AKALVENGVDYLAVATVEEALELRSYGITAPVLILGYTPLSQAGEAVEKD
VTFTAFDLKYVKELGEIASRKGKKAKIHVKIDTGMGRIGYTDFDLAEREI
EEMSKLEGIELEGIFSHFATSDEKDKDYAREQFERFADMLKRLEKRGVNI
TLKHIANSGAITDLNYAYLDMVRPGITLYGSYPSNDVNKILDLRPAMNFK
TKIVYIKEVPENTSISYGRTFITKRPSKIATLPIGYADGLNRLLSNNHEV
LVRGKYVPIVGRVCMDQTMIDVTEVEGVEVGDEVVIFGEQEGKRITADDI
AKKLRTIPHEVYCGISRRVPRIYIYRGEVFDVKNYLKI
>TTE2217 AmiC, N-acetylmuramoyl-L-alanine amidase
MRLKRWLLFGLLLLVSVFSYNWQTKNLSVFTTLPIMNKIIVIDAGHGGYD
PGKPGKYGKDEDELNLEIAQKLKELIEHTGGIAVMIREDDSLSDSSLSKD
LKNRVLKANQVEGDVLISIHQNSFSQSKYKGAQVFYQQNSEKGKLLAELI
QEELRKTLDPNNDRMAKSSNSYYILRNAKMPAVIVECGFMSNPGEERLLN
DPNYQYKIAWAIYKGIIAYFQKTSE
>TTE2424 AmiC2, N-acetylmuramoyl-L-alanine amidase
MLIAVDPGHGGKDPGAVVDGYKEKDINLNVALKLRDILTKNGIDVIMTRD
KDKTVDLQQRCDIANKAHANYFISIHCNSFQDPSASGTETYAYPGSVDGR
NLAQYVQNEIVKMLGTKDRGVKYEKFYVLKYTDMPAILVELAFMSNPHDL
KLLLEKDELFAEAISRGLENFLKTTFTGEEMAIQKLKMKGIIDKIHDTKS
YVTWGEFASVIIKVLEGMK
>TTE0925 DacC, D-alanyl-D-alanine carboxypeptidase
MAKKIIALLIIIVFAFLSVPAHAETPQPPEIVGPTAVLMDFTTGQVLYDK
NMHKRMYPASTTKILTAIIALEKGKLDDVVTCSENVTKIEGNSIFLSPGE
QLTLEQLLYALMLESANDAAIAIAEHIGGSVENFAKMMNEKAREIGAYNS
HFVNPNGLPDENHYSTPYDMAQIARYAMQNAEFRKIVSTLHYQIPPTNKF
DKPRDLWISNRLLKPSRFHYEGADGVKTGYTVAAGQVLVASATRDGHRLI
SVIMGDEGINIWTDTIKLLDYGFQNFSLVKVTQKDEVITSIELGKGGFKL
PLIAQKDFYYEVPKGKENSIKTEVVLKEDIKAPIQKGEVLGYIKYTLDGK
EIGTNPLIASEDVYKNFLGNYYNEKEKNPIVHPLKLIFGIASFSMAFLLW
RRQRIRQRKKFIFSKY
>TTE1314 DacC2, D-alanyl-D-alanine carboxypeptidase
MSKKFLALLISTFLLFNTAYADVMNLKAKSAILMEAETGEILYEKDIHKP
LPPASVTKVMTLLLAIEAIDSGKIKVTDKVVTSKHAFDMGGTQIYLEVGE
EMTVDDLMKAIAMNSANDASVALAEYIAGTEENFVEMMNKRAKELGAKNT
TFKNATGLPEEGHLTTVYDIAMISRELVKHPSIFKYLTNKIDSLRNGKFS
LINTNKLLWRYKGVDGIKTGSTSEALYCMAATAKRGDTRLIAVVFGAPDS
ETRFNETAKLLDYGFANFETVKVASKGEVLGKIKVLKGNKEMVEGISLKD
EYVVVKKGEGKNIKKEVELKNFLTAPVSKNNPLGVLKILQEGKLIKTVDI
YPATDVKKANFFENFNKVINYWIKKGS
>TTE1328 DacC3, D-alanyl-D-alanine carboxypeptidase
MKKYFSLLLILMFFVTFSKVYGSDIPSVSAKAAIVMDQNTGRVLYEKNAH
LKLPMASTTKIMTLLIALERGNLNDIVTVSQKAASVGGSSIWLSPGEKID
MESLLYGIMLNSGNDAATAIAEHIGGTVENFVEMMNQKAKEIGAYNTHFV
TPSGLDIGIDDHYTTAYDLALITRYAFLNYPKFAEIVSTKEKTIPCEGKE
WDRYLRNKNKLLWIYEGADGVKTGFTNKAGRCLVSSATREGRRFIAVVLN
SPPMWEDSMKILDYAFSRFKPFKVFERNDVVKKVKVEKGKIEEIEVAVEK
DCIIPVSEEEIGKVNLEFHIPDKLEAPIKKGEKIGHVVVKIGEEKVCEVN
CLSFQEVDRQDFVYNFKRIIKKWIEIFNPS
>TTE0832 DapA, Dihydrodipicolinate synthase/N-acetylneuraminate lyase
MPVFKGSCVAIVTPFTENGVNFDKLGELIEWHIKEGTDAILICGTTGEAS
TMTDEEQKEAIKFTVEKVAKRIPVIAGTGSNNTAHAIELSEYAQSVGADA
LLVITPYYNKTTQKGLVAHFTEIARHVDIPIIIYNVPSRTSLNMLPETYL
EVKKKAENVVGVKEASGDISQIAEIARIMGKSFEIYSGNDDQVIPIMSLG
GLGVISVTANIIPAKIHEMTTAYLNGDIEKARDMQLELNPLNKALFIETN
PIPVKTAMNLMGFGVGPLRLPLVEMSEKNLEYLKSVLRQYGLLKEEN
>TTE0068 DdlA, D-alanine-D-alanine ligase and related ATP-grasp enzymes
MKVGVFWRRFRNVELQRRLTPDKVYDDAYDEAYHHYEALKEAGFDAVLIE
WKDDPIKTYEVIQKEEVDIIFNASSLKEIEFLELFNIPYVGSGIDLAATD
KRMRKDIVAAHGLPTPKYVVAYSANEIPSVDHLRFPLFVKPIMGRGSAGI
DEENIVYDKSRLPKVVSKITEKIGQPALIEEFIEGREVTVGIIGYRNPIV
LPLLEIGYNNVKTNTYEHKMFDNEIIKCPMEVPEEIEKRIKDTALRIFKV
LNARDYARIDMILGKDNVPYFLELNTYAGLTTAVERGEKHVHHGYMGYMA
KAAGMTRKEFIGKILESALERYGFEDKELLLA
>TTE2545 DdlA2, D-alanine-D-alanine ligase and related ATP-grasp enzymes
MLKVAVMFGGKSVEHEVSIITGLQVIENMNKEKYEPIPVYVGRDGRWYTG
KGLLDISNYKDIPSLLKKCEQVVLPPVPGLNKLYYYPFRKKFMSKEYDYI
DVDVIFPAFHGTHGEDGTMQGLFQLANIPYVGSGVVGSATGMDKVIMKDI
FKANNLPIVNYLWFLRKEYEKNKEAMLDLIESKLKYPMFVKPANLGSSIG
ISKAKNRDELFDAIEIAIYYDRKIIVEEAVKDPMEVNCSVMGIDRDLEIS
LCEMPVPWEEFLSYQDKYMRKEKGGKGSTTRQIPAPIPEEKTKEIQELAK
KVFQILDCSGLARIDFLLEKETMKVYVNEINTIPGSFAFYLWKPLGISFE
KLIDRLIEYAVERHKEYARNMYTFETTLLLKAADRGTKM
>TTE2535 DdpX, D-alanyl-D-alanine dipeptidase
MSDKNFKEIPISTPIEKWNWEEVRKIPIRENNEKLVPLSLYPERIIVRSE
YFLQGIKGALPECYVRESVYEKLLEAADLLPPGYKFVIFDTWRPIQVQQS
LFDTLKEQFRKQYPSESEEEITKRTLTFVALPSTDPTRPSPHNTGGAVDL
TIADDKGRLLNMGTEYDDPTEKARTTYFEELLKEGKELSKEEREALENRR
LLFNIMTSVGFTNYLDEWWHYDYGNQNWAWVSKKEYALYGRAKPFFAWRS
DIE
>TTE0174 FlgJ, Flagellum-specific muramidase
MEINPIEGAIKNMLPLWGNQQVEDFERIINKAMEEKDKDKLMEACKQLEA
NFISLMLKEMRKTIPEDPLTGNNLANDIFTSMLYDKYAELMAQSGGFGLA
EEIYNQLSKKV
>TTE0901 FtsI, Cell division protein FtsI/penicillin-binding protein 2
MSEALKKRFYVLASIIGILLLLLVSRLVYLQLIKGDYYREISIKQAIRLI
PIDAPRGEIVDRYGVKLATNRPSFSVDILKGEVVDSHLNETILKLIHLLE
KNNVKYKDDLPLYLNDKGEPYFNFKNPDEGDVSPETLKEREKAWKKANNI
NESATAKETWDILMKKFKISKDLSPQDARKIMVVRQLMEEQGYNQYQPVE
IAVDVDQKTVAEIEERHLELPGVMINIKPIRYYPYGTLLSQTLGYIGRIT
PEDLKKLDIKKYKLTDLVGHSGIEALYEEYLHGKDGGQQVVVDNYGRLIK
NLSTVPPVPGDTVFLTIDKNIQEAAEEALINTMQKLREGKLGKPRPNAKI
GAAVVVDIHSGKILALASVPGFDPNIFATGSPPKDVVNELFRERDATVDP
SPIFNYATQGAVPPGSTFKMIVALAALETGVTTVDEKYLDPGVYITGQTN
WLWNEYGRTQGWVNVSDAIKYSTDTYFYEMGRRMGIDKIVEYAKKFGLDQ
KTGIELPEAKGIIASPQYKREFYLALIRSMVKSERNPDGPITEEQYNKIV
EIVDKGDLSDYNTFLKLEKMGIKDPKLQRKLWEMMYYARHWSLADTCSAA
IGQGDNQFTPLEIASYISTLVNGGIRYRLHLVDKIVDAEGNIVKKTEPEI
LGKIDIPKKYLDAIKLGMKGVTERGGTASAAFDGFPMTVGGKTGTAEVGI
KGRDNYAWFVGFAPYDNPQIVVVTVIYQGGGGSYAAYVARDIFDAYFGLS
KSGERETFNLVNTPLR
>TTE1258 FtsI2, Cell division protein FtsI/penicillin-binding protein 2
MEKRIVFLRIVLALMIFILAGRLFYIQVVKYNFYSEKAMEQRIKSFKISE
KRGDIYDRNMIPFTDRDYKEYVFAIPKMINDKKRAAEILSEITEISSEKI
REDLKRNKDYIRYEIRRDVDFSLPVGIFKLELPQRYSSNSLARHVIGYLG
DKKMGLEESFDEVLATDASDSIAVFTDGSRNDYIKGLGVKIQTVHDKVFG
VKTTLDYHIQKVVEDVLDRRRIEGAAVVLEVKTGNILAMASRPNFDQNRI
EDYLKSSNEEFINKAVSGYPPGSIFKIIVAAAALESGKVSLEDTFYCSGS
YDINGVVFHDFKGESHGLINIVKGFAVSCNTTFIRIGEITGAKAILDMAR
KFGIEKDDGLPIPEQIGRLPKLSDTYGAGIGNLSIGQGEVLMTPLQAADI
VATIANDGIRNVPRLVEAVVDEKGEEVKRFPPRESYRVLESNTAKILRYM
MRQVVVDPEGTGKRAETFCKSAGKTGSAEVNKELNIYHAWFVGFVPYENP
KYSIAVFVKNGDTGGIKAAPIFKEIAEEIIKY
>TTE1651 FtsI3, Cell division protein FtsI/penicillin-binding protein 2
MLFLSFAVVFGLMMRLFFIQVVKGEEYQKMALPQWTLDVSLSGKRGYIFD
RNGKVLAENASVSKISVIPKEIPDSKRQVVAETLASILGLDRQKVLERIS
NKNLQEVLIAKQVDEEKAKAILRLNIDGVIVSEDMKRFYPEGTLACHVLG
FTGIDNQGLDGIELVFDNFLRGIPGKSTTPMDAIGRKIDTGEEEYFEPLP
GYNVVLTIDETIQHFAEKALNQAMVHSKPSKGAVAIVMDPKTGEILALAN
RPNFDPNDPFEGPEEEWYRRWRNKAISDSYEPGSVFKTITASAALEEKVV
SLHEQFYCPGYTTVAGHRINCWATHGSEDFVKGVQNSCNVVFVTVGQRLG
VEKLYKYIRDFGFGKTTGILLPGEAPGLVLSEERVGPVELATNSFGQGIA
VTPLQMITAVAAIANGGKLMQPQIVKAIVDSKGKVVKEFKPKIVRRVISK
ETSATMREILKSVVAEGTGKAGYIEGFDVAGKTGTTEKYMPGKYVASFVG
FAPADDPKVIVLVVIDEPNNPETHFGSQLAAPVVKSILDDTLKYLEVQPR
GVKKPETVMVPDVRNMKLYEAERIILENKLDFILQGNGDTVFDQVPKPGA
LVNENTKIILYLNGVSTEEVVVPDLKGKSVKEATEILNSLGLRIKIKGTG
FAVDQSPKEGTLVKRGEVVEVEFRPKEN
>TTE1916 FtsI4, Cell division protein FtsI/penicillin-binding protein 2
MTKSLKLRTFFLFVFFLILFSILIGRLVWIQVVNAEKLSLAVERQTTADI
IIRPQRGNIYDVNGNILACNVPAADVYASPKYIKDPEKASEELSKYLSIS
KEALFKVLSKKDLEWTVLERFVPMEKALSIKKLNIPGIYVEDTSMRNYPN
GSMLSQVLGFTGVDGYGLYGLEYSLDRYLSGVPGREISLVDREGHKVGIP
SKYYKPKEGEDVVLTVDSVIQAYTERAIKKAYEKYKPEDGITAIVMNPKT
GEILAMANLPDFDPNDPQKVPSQEYWANPAVSSIYEPGSVFKVITAAAAL
DSAVVTPEEQFFDPGYYEVSGKKIRSWTVLGNITFSQAIEKSSDTVFIQV
AERLGLDTFYKYIQAFGFGAPTGIELPGEASGMILPKDKVYPVDFATMSF
GQGIAVTPIQMITAFSAVINGGDLMYPHIVKYIKSEGKIVKEFKPQVVRQ
VISKETSDTLRYILEKTVTEGTGQLAQVPGYRVGGKTGTTENYQKGKYTA
SFAGFAPVENPKIAVLVIVKNPTQGGHMGGEVAAPIAQEILKDTLTYYEA
VRK
>TTE1967 FtsI5, Cell division protein FtsI/penicillin-binding protein 2
MSNLKRNIKILFGIFALLFFSLIAYLTYFQLYERDKLITSSYSVYNRRLI
EQEKKILRGSILDRNGIVLAKSVIEADGTQKRIYLDGPAFAQVIGYSRRI
YQQGSTGIEKAYDRELLGMVGSDPMVLLRKLILGKGQIGDNVYLTIDKAL
QDLAYREMEGKKGAVVALNPKTGEILAMVSTPSYDPNLLDRDWEKIMTSP
EHVVLNRATQGLYPPGSTFKIITTAAVLTYMPELFKEVYDCKGYVVVDGN
KISDFGGIAHGKENFERAFYVSCNSFFIEIGLKLGSDNLEKMAYAFGLNQ
RVPLEIDTAKNYFPSIDGKVALAETSIGQGKILVTPLTMALAASAVANDG
VIMKPYLMKYVVDPLSGAVIERNTPSKYLTPITKEVADAIKSLMIGVVNN
PEGTGRLAQIPGITVAGKTGTAENPFGAPHAWFVAFAPAENPEIAVAVVV
ENGGEGGKVAAPIARDIIKAYLSR
>TTE1643 FtsQ, Cell division septal protein
MNKRAFRVIFFLLILAVLSYVFAFHTNYFKIKSIKVVGNQILSYNDIKEI
SKIQAGTNIFKVNPKQVEKNLLENPYIKECKVKILYPNRVEIFVEERRVV
AQVRYKSDYLKIDKEGVIVEKGSFTPGLLLIEGIKVERYQIGKKLNGNFD
KTLLSEVLGLIESKSNYYALRYIKEDEVELLSKQGINIFLKNPADVNYSF
KFAELILKDLLKKGYKSGKIEIIGDGNAVFMQ
>TTE1927 GalE, UDP-glucose 4-epimerase
MAILVCGGAGYIGSHAVYALLKRNEEVVVVDNLATGHSESVLGGKLYIGD
LRDEDFLDKVFSENDIEAVMHFAASSLVGESVENPFKYYENNVCGTLSLL
KAMKKHGVKKIVFSSTAAVYGEPERIPIEEEDRTEPTNPYGETKLAIEKM
LKWADAAYGIKYVALRYFNVAGALETGEIGEDHSPETHLIPIILQVALGK
RDKVMIYGDDYPTKDGTPIRDYIHVMDLVDAHILALEKLRKENKSEVYNL
GNGEGFTVKEVIEVARKVTGHPIPAEVTGRRPGDPAVLVASSEKAMKDLG
WRPKYASLEEIIKSAWMWHKNHPNGFKRD
>TTE0732 GalU, UDP-glucose pyrophosphorylase
MKIKKAIIPAAGLGTRFLPATKAQPKEMLPIVDKPTIQYIVEEAVQSGIE
DILIITGRNKRAIEDHFDKSVELELELKKKNQESLLSLVEDISNMVNIHY
IRQKEPKGLGHAIYCAKSFVGNEPFAVLLGDDVVDAEVPVLKQMIEQFER
YNCTIIGVQEVPEEDVHKYGIVSGTFIEDRLYKVNDLIEKPRREEAPSNI
AILGRYIITPRIFEILEHTPPGRGGEIQLTDALKTLLNYEAIYAYNFIGK
RYDVGDKLGYLMATVEYALKREDLREPFKRYLITIVQDLLGMEEAAVTER
DV
>TTE0065 Gcd1, nucleoside-diphosphate-sugar pyrophosphorylase
MKALLLAGGLGTRLRPLTDDLPKPMVPIMGKPLLERIILNLKKSGVDEVV
ISTHYKSDYIENYFKGKSKELGVKIHYVTEETPLGTGGAIKNAEKFFDDT
FLILNSDIVSDIDYADLVKYHKRRRAQVTIASIEVRDTSQYGVIEFDSKG
FITAFKEKPKPGESNSKYINAGVYVFEPEVLKEIPANTQVSVERETYPLL
LSKGYKMAIYKFTGYWMDIGTVDKYKKVHEDILKGKSRFVAGLSTRGIIL
GENVKIHPTASVIGPAYIGDNTEVDAYATVGPYTVIGSNCRIGQESKVSN
SVLWDNIKVRRFARLENSVVTSECVVEVNMEIKNTVFTANKLADITLTP
>TTE2013 Gcd1.2, Nucleoside-diphosphate-sugar pyrophosphorylase
MKGIIMAGGEGSRLRPLTFDIPKPLVPVANKPAIKHIVEHLHKYGVGELA
VTLFYLPHKIKDYLLEEYGNEIKFYTEEKPLGTAGSVKNAKDFLKETFIV
MSGDVITDVNIKEVYDFHRKKGSKVTLVLKKVEIPLEYGVVIVDETGKIV
KFLEKPSWGEVFSDTVNTGIYIIEPEILEFIPEDRPFDFSKDLFPLLLKE
NIPMYGYITEGYWCDIGNTAQYLSSHFDVLEGKLDLGYRKILLEEGKVIG
KKVLMSSGAKLILPLIIGNEVVIEENAVVGPNVVIGRGTIIKKGSHVKNS
VLWEDVYVGENSELNGAVVCNKVRIDSNARILENAVIGEGVRIKAFAEIR
PDVKVWPFKVIEEEAVVSKDVVWGNGRKNLSFGYRGIRGIFNEEIGPYQA
VEIGEAFGDLMKGKVIVGSDEELASSLIADLIAYGLAFSGCEVLKSNSFL
LPALRVGIRLRSAKGGVYVERIGEEIRILFLDGEGMDIDRNLEKKIENKL
KIHDISRRKIEDIKPIKEVDVEGDYKDYLVKNRADSFKIKVKPHDEWTKK
VLLQIKGEQILDDQNYHLKVKLKKNGEEIELYDEKDRKFDEDEVNYLKML
IAREKGLKKVVLPFNSSKYLAEFAEELAVETVVGKISPRDLMRSMTNLEE
GRQVYFDLSFDGINFLLEVIEYVRLKNKRLSEIKDSFPLRYKTVKRIRCD
WKDKGRIIRELFETRKNNVTFLDGLRFEEDEGWVLVVPDSELPFCNVYVE
ALTPEKAERLFTIYEKKIQDILLKNDGK
>TTE2794 GidB, predicted S-adenosylmethionine-dependent methyltransferase involved in bacterial cell division
MKQKSIEMLVQGASSLGITLEMFHVEHFQKFYSLLLEWNQKMNLTAITEE
EEVVIKHFLDSLSVIKSGKIKGGEKVIDIGTGAGFPGIPLKIVFPEIGLT
LLEASKKKVNFLNFLSQVLLFEGIEVIHGRAEELGKVERFREKFDIATAR
AVAPLNILLEYAVPFVRVGGHFIAMKGRDIEEVYQCKNALEELKCEIEDV
IEVRLPFSDILHHLIVVKKVDVLPSKYPRREKAIRTKPL
>TTE2190 GlmS, Glucosamine 6-phosphate synthetase, contains amidotransferase and phosphosugar isomerase domains
MCGIVGYIGDKQATPILLEGLTRLEYRGYDSAGIAILHNGNINIKKAKGR
LNVLRELVEKDYMEGTIGIGHTRWATHGEPSDTNSHPHLSQSGLIAVVHN
GIIENYLPLKKWLIEEGYNFISETDTEVVANLLEYYYNGDIVEALRKVLD
RIEGSYALGVLCKDNPDMIVAARKEAPLIVGIGNGENFIASDIPAILKYT
RNVYFLDDHEIAIIKKDSVEFIDVFGRKIGKSLFEVKWDVEAAEKGGYEH
FMIKEIHEQPAAIKDTLRGRIINDSQIVLDNINITKEDLEKIEKIFIVAC
GTAYHAGVVGKYVIESFARIPVEVDVASEFRYRNPIVNERILTIVISQSG
ETADTIAALKEAKRKGSRVIAITNVVGSSVSREADEVLYTWAGPEIAVAS
TKAYTTQLIALYLIALDFALKKGTMSSTKVVEIISELKKLPDKVQYLLDN
KEVIQKFASEHYNVKDVFYIGRGLDYAVAMEGSLKLKEISYIHSEAYPAG
ELKHGTLALVEEGTLIIALATQDDLFEKMLSNIKEVKARGGYVVAFAKQG
NLQLEGVVDKVIYIPDTLKELTPVLTVVPLQLLAYYMAVEKGCDVDKPRN
LAKSVTVE
>TTE2572 GlmU, N-acetylglucosamine-1-phosphate uridyltransferase (contains nucleotidyltransferase and I-patch acetyltransferase domains)
MEELVSVILAAGLGKRMKSKYPKVVHKVCGKPMVKWVVEAAQEAGSKEVI
VVVGHGREMVEEVLGDEVKYAYQKVQLGTGHAVMMAEEFLPLEGMVLILT
GDTPLITSDTLRKLVEYHISEGNDVTILSSIFDDPTGYGRIIRDESGNVV
KIVEEKDASEEEKRVKEINSGMYVVDIAKLRAALKEITNDNAQGEYYLTD
AVEIIRNMGGKIGAVVGESEEIIGVNSRVQLSNAEKVMRRRINEKHMENG
VTIIDPDSTYIDAEVEIGRDTVILPGTILQGKTKIGEDCEIGPNSRIVDS
TIGNGCNVMYSVVLSSSVGNNVKIGPFAHIRPESVIKNNVKIGDFVEIKK
SVIDEGSKVPHLTYVGDAELGKNVNMGCGSITVNYDGKQKHKTIIGDNVF
VGCNVNLVAPVKIGNNAYIAAGSTITEDVPEGALAIARSRQTNKEGWVEE
RIKKGRL
>TTE0951 LepA, Membrane GTPase LepA
MSERMKYIRNFCIIAHIDHGKSTLADRLIEKTGFLSEREMDKQILDNLEL
ERERGITIKLKPVRMIYKAKDGNEYELNLIDTPGHVDFTYEVSRSIAACE
GALLVVDASQGIEAQTLANVYLALEHDLEIIPVINKIDLPSADPERVKRE
IEDIIGIDASEALLTSAKEGIGIEEVLEAIVKRIPPPQGDEDKPLKALIF
DSFYDNYKGAISFVRIVDGKVKRGMRIKMFSTGKVFEVTEVGSFRPDLYP
VEELKAGEVGYIAANIKNVKDTRVGDTITDADNPADSPLPGYKEVVPMVF
CGIYPADGEDYENLKEALEKLQLNDASLVFEPDTSAALGFGFRCGFLGLL
HMEIVQERLEREYNLNLVTTAPSVIYKVYKTNGEVLELDNPTKMPPPTQI
DHIEEPIVEATIMVPTDYVGPVMELCQERRGVYLGMEYIEKTRVLLKYEM
PLNEIIYDFFDALKSRTRGYASLDYEFKGYKKSDLVKLDILVNGEVVDAL
SMIVHKDKAYEKGRKIVEKLKENIPRHLFEIPIQAAIGSRIIARETVKAL
RKNVLAKCYGGDVTRKKKLLEKQKEGKKRMRQIGTVEIPQEAFMSILKLD
DQK
>TTE1744 Lgt, Prolipoprotein diacylglyceryltransferase
MDIPSLSPYAFKFGPIAVHWYGIFMAISIAVGGYYLYKQATKLNYDEDFL
LNLLMIVVIFGVIGARLMFVLANYPEWFVKDPVQVFKIYEGGLSWHGAVL
GGFLAGLYYCRKKGVRINPLEDFAVVGLALGNMLVRVGNIFNHEVLGRPT
EFFFGRWPAQLVGVAIGAFLLIRYFYVQKKHMPDGYQFWSFIFYYQLLRG
VFEETVKDVPLVWPVYLNEEWGIGLFTMTQVATPFILILAYWMIKRVLND
PNRQYYD
>TTE1539 LspA, Lipoprotein signal peptidase
MAIVIVAFVVFLDQFTKYLAAKYLMPIGSYPVIKHFFHLTYVENRGAAFG
MLQNKTLFFIVITVVVGIVLIYSMIKLPENSLYNYTLAMILGGAIGNLID
RVRLGYVVDFIDFKFFPAVFNVADSFIVVGAIILGYLMIFKGGIR
>TTE1352 LytB, Penicillin tolerance protein
MEILIAEHAGFCFGVKRAIEIAYEELNKQKDTRLYTLGEIIHNPQVVKDL
EEKGVRVIEEEELEKLLKGDRLIIRSHGISKKLYEFLEQKGVEIIDVTCP
FVKKVQNIVEEYYKKGYDIVIVGDKNHPEVIGVNGWCEDKAYIVNSVEEA
ENLPFFEKACAVSQTTLIEKHWEDILEVLKSKAKELVYFNTICNATQKRQ
EAADALSKKVDVMFVIGGKHSSNTQKLRKICEKNCKNTYHIERADEITFE
MLKGHDIIGITAGASTPDYVIEEVIEKIKSLKGEDENE
>TTE1018 LytE, LysM-repeat proteins and domains
MSKVHLKVKPLIALIIGGLFLFQAAFAATYTVKPGDTLWGISQKYGITYT
KLMALNGLQTTTIYPGQVLQVPGNDNTYVVQKGDSLYLIAKKYGITVDAL
KAANDYKSDIIYPGQVFIIPKPVNSSSRTYNDVSRGYVQRSVIPYTPEEF
DLLARLVTAEADGEPYQAKVAVAAVVINRVKSGIFPNTIKDVIYQVDAWG
NYQFTPVLNGWINRPASTDAIAAARDALNGIDPTNGALYYFDQSSTNAWL
WSLPIAARIGNMVFCYGK
>TTE1337 LytE2, LysM-repeat proteins and domains
MTIDGYTPYYPHHPHPEHCRSFYTVQPGDSMWSIANKFGISLDCLIKANP
QIRDPNLIYPGQQICIPFYCPPVSYEQCRTIYTVRPGDSLWSIANMFGVS
LDCLIKANPQISDPNLIYPGQQICIPFYCPPPSPQTCRTIYTAKAGDSLW
SIANMFGVSLEALIKANPQIPDPNLIYPGQQICIP
>TTE2560 LytE4, LysM-repeat proteins and domains
MPQVYKDILEFDVVAGSYNTEFLVEGDIIVPENDPDILTILAVNPRSYIE
EVFVTSGKVQFEGKLNLELIYISEKDGEIESIEKEVDYSHTIEDETIDKR
SRCLARVSVENIDYRLVNSRKVNVKAVVRIQSRLLVSDKREVVIGGEEAL
ALQTLKKRVKLVHTVGQNTGEVFVKEKVKVGDEDRPIKKVIKKEVKVVPE
EVKLSENKVIVQGKVQCRILYVSEENEVKSLDATLNYANFIDVPGTLSYM
KANTYEDVINVDVTVTQDEKGENRLVDVEVTLKVKVEVLEEEEREIPVDA
YGIEKYVEPLKENIKVLGDIKSFSSQFMVKTEVELPSVVRKVLEIFALPI
VSDYALDGDKLILEGILNYTLLYVSEDGGIKGYRDEYPFRTFVEIEGEVG
EVLTEVSTAYVSYEINSLKELEFKFAIDSCVEVLTEKEMTLIYDLKEIEM
PRGEEVRHSIIIYMVQKGESLWDIAKRYRVNVEDLITANDLKEDKVFEGE
KLIIPVKK
>TTE0876 MltE, Soluble lytic murein transglycosylase and related regulatory proteins (some contain LysM/invasin domains)
MIKRWVLFLLIILAILLTFEMNTHYFLKKFYPLKYEEYVNSYSKEFGLDP
YLVFAIIKVESNFNPYAISNRNAIGLMQIMPDTGRWIAAKLGMKDFKEEI
LFNPEVNIKMGVWYLHYLLKNFDGNLKLALAAYNGGCGNVDLWLKDKRFS
QDGRQLHSIPFPETDRYVKKVLAVYQMYKFIYTKK
>TTE0883 MltE2, Soluble lytic murein transglycosylase and related regulatory proteins (some contain LysM/invasin domains)
MSNYKSEVKKIMIDSVINSIIEEKFKEIQSRLPANVKIFSTSLNFQEILN
SEIENINQKDSPSEIEKLIREASQKYGVDANLIRSVIKAESNFNQFAVSP
KGAMGLMQLMPSTAKELNVKNPFDPSQNIDGGVRYLKNLLDTYKDVRLAL
AAYNAGPQAVEKYQGIPPYPETINYINKILNDLYK
>TTE0314 MrcA, Membrane carboxypeptidase (penicillin-binding protein)
MDKNSDLNLKRSRRKKNSEKKKKSSIKLFFKWVGIAFLILFFAAVGAIGG
KVLAIIKNTPPISQEALTSQAQSSVVYAKDENGNWQRVAILHGADNRLWV
PIEKIPKNLQNAFVAIEDQRFYKNKLGIDPKRIIGALIADIMAGGKPVEG
ASTITQQLVKNTMLSSEKTITRKIQEMVLAWRLEQIYSKQQILEAYLNTI
YLGGPNVNAYGVQAASLAYFGKDVSQLDLAECAMIAGITKNPSRYSPYAD
LEAATERQHLVLKKMLEQGYITKEEYEKAISEKLVFKKTNFTTYEHKYFI
DQVINDVADALSQHLNISHDEAIKKIYNGGLRIYSTMDLQIQKTMEEAFK
NPKLFPPDIKDRSGNTRIVQGAMVVMDWKTGEVKGIVGGRETEETKGKTR
IFNYATQGGRPAGSSIKPLTVYGPALEKGYTAATVVDDVPVFYKQWNWEP
HNYESGKYRGLMTFREALTYSENVPAARIVVEMIGLHTAAEYGKKFGLTV
TKDVASSPAALALGAGGAVTPLQEAAAYGAIANGGVYTTPITFTKVTDSK
GKVILENKPSQHMVLTPQNAYILTSMMQDVVKYGTGTNARLPNMPVAGKT
GTNESYNDAWFTGFTPYYVGSVWMGTGENIPMIYGGRGVVGGSYPAMLWR
TVMAEIHKSLPYKDFERPPGIISVTVCKDSGELPTDLCHQDLRGDRTYTE
IFAEGTQPTTYCTVHVLAKINSQNGKLATEFTPPDLVKEAVFIDPPGRTP
EQNAVALDGKYVVPKDYDDTPPPAQPPSGEVLPPENTQNPPSQPPNEIQQ
PPGNTPPNNGGNNGTTQNPPQNNNNNTSSNPLEKIFPPKNSKP
>TTE0899 MreC, Rod shape-determining protein
MPRFFRNRQLILVLLIAVALIAAMAYTYDTERYLTKAESVIGSVFTPVGK
VFYRMTNGISDFFSSIREIGTLRATNEKLQKEVEKLRKENIELQELKNEN
LRLKEALDFKTENPELDLKLASITGKNPGNWFNIFTIDRGKRDGIKPGMA
VLDEKGNMVGQVTQVGDNWAKVLAIIDRDSSVSAVDVRTRDNGIVRGDSQ
GGLVMIYLPLDAEVLEGDIITTSGMSRFPKGLVIGKVEKVTKEPGALFKQ
ALVKPAADFERLEYVFVVLNMTETGK
>TTE2783 MscS, Small-conductance mechanosensitive channel
MWADIYHKLVEIYDIKAVKFLLDVLKILIIAFIGIKFADFLIYRFYKLYS
KSKIQLPQRKIDTLTSLTKNAVRYIIYFLAGASILKLFNIDMTSLLAVAG
IGSLAIGFGAQNLVKDMISGFFIIFEDQFSVGDYVTINGISGTVEEIGLR
VTKIRGFSDGLHIIPNGEIKMVTNLTKDSMMAVVNIAFPIDEDVDKIIEG
LQEICEEVKKSRDDLIEGPTVLGITDMQDSKLVIMVYAKTQPMQKWAVER
DIRYRVKKMFDQKNISFPYPRTTVILSEKKTN
>TTE0158 MurA, UDP-N-acetylglucosamine enolpyruvyl transferase
MKTKFVVEKSPPLKGTVKISGAKNSVLPIIAASLLSSDEVILEDIPSLED
VNVMIELIKNFGALCELDNGKLKIKVDIKDVEAPYELVKKMRASFLVMGP
ILAKLGHAKISMPGGCAIGARPIDLHLKGFQSLGADITIGHGYVEARAKK
LTGKKIYLDFPSVGATENIMMAAVFADGVTVIENAAEEPEIVDLANFLNK
MGANIKGAGTDTIRIEGVKELKGAEHTVIPDRIEAGTFMVAAAMTGGNVL
IENVIVDHVRSVIAKLTECGVKITEEKGGLRVKGVKNYKAVDIKTLPYPG
FPTDMQAQMMAMMTVAKGTSVIIETVFENRFMHVSELKRMGANIKIEGRS
AMITGVDHLTGAEVKATDLRAGAALVLAGLIAEGRTEINDIYHVDRGYVK
MEEKLRALGAKIYRK
>TTE1644 MurA2, UDP-N-acetylglucosamine enolpyruvyl transferase
MGKFKINGGKRLYGEVEVHGAKNSILPILAATILNEGVSVIHNCPRLKDV
DSMIEILEHIGCKVSFSGRDIVVDARDVKDSEIPDNLMRTMRSSIFLMGA
LIARNKKAFISFPGGCDIGHRPIDLHLKGLKKLGVEIEESYGYIRCKGVR
VRGNEIHLDLPSVGATENIMLAATLADGITVIRNAAKEPEIEDLQNFLNS
MGARITGAGTNTIVIEGVKKLHDTEYTIIPDRIVAGTYLCAAAMTRGELT
VVKALKEHLEPLISKLKETGCELKTGNDYIKITCNKRPKAVDMIVTLPYP
GFPTDLQPQIVSVLSIAEGTSIVTETIFDNRFKYTEELVRMGADIKVEGR
VAVIRGVDKITGAKVLAKDLRGGVALVIAGLGAEGTTVVEGAEHIDRGYE
SLEKALKSVGADIVRIM
>TTE2684 MurA3, UDP-N-acetylglucosamine enolpyruvyl transferase
MEKFVIRGGKPLRGTVQISGAKNSAVAVLPAALLADSPSVIDNLPDIKDI
ETLAEIIKRLGGKVEKGKHEIKIDPTGLNSFHPPRELASRMRASYYLIGA
LLSKFNEAIIPMPGGCNIGVRPIDQHIKGFEALGAETTIEHGFIRIKAEK
LRGAHIYFDVVSVGATINLMLAAVKAEGVTILENCAKEPHVVDVANFLNA
MGANIKGAGTDTIKITGVDKLEGCHYTIIPDQIEAGTYMVAAAATGGDVY
VKGVIPTHLESIIAKLVEMGVIVEEYDDVIRVRREGPLKRVDIKTLPYPG
FPTDMQQPFAVLLALADGISVITENIYENRFRYLEELKKMGMKVRVEGRS
AIIEGVGKLTGAPVYATDLRGGAAMVIAGLAAEGITEVLDIYHIDRGYEA
MEVKLQALGADIIRIRE
>TTE1836 MurB, UDP-N-acetylmuramate dehydrogenase
MAEILVDKLKEILKEGKLYLNEPMKRHTSFKIGGPADVLAVPGSRDELIN
LIAYLRQEKIPFFILGNGTNLLVSEKGIRGVVVKLSSLRNVIVEGTKIIA
EAGASLSYIANVALVHELTGFEFASGIPGTLGGAIVMNAGAYGSEMKDVV
EKVEVLDENNNILILSNQEMKFSYRYSILQEKEWIVLRAWISLERGNYEE
IKKKMEELNQRRKEKQPLDYPSAGSTFKRPPGYYAGKLIEDAGLKGYSIG
GAKVSEKHSGFIINTGNATFYDVLNLIEYIQKVVKEKFGVELMPEIKIVG
EK
>TTE2575 MurC, UDP-N-acetylmuramate-alanine ligase
MEIDLEKFKRIHFIGIGGISMSGLAHILLEEGHTITGSDIKNSHLIERLE
KEGAKINIPHMAESVIGADLVVYTAAIHDDNVEYQKAKELGIPIIDRATL
LGLIMKKYKFGVAVAGSHGKTTTTSLISVILDRAGYDPTVLVGGEIDAIG
GNVRVGKSEYFVTEACEYTDSFLKFYPYIAVILNVDSDHLDYFKNIDNIK
QSFRQFASLVPSDGFVVACKDDANTMHVIKGLEKNIVTYGINEKSDWQAK
DITYDEKGCASFNVYYRGKFIGHFKLSIPGKHNIYNALASLAVTYLLGVD
TEKAKEYIKEFKGTHRRFEVKGVVEGVTVVDDYAHHPAEIHATLEAAKNY
PHKRIIAIFQPHTYSRTKALLSDFAESFDAADKIIITDIYAAREKDTGIV
SSKDLVDLIFKRGKDVLYIKDFDSIVEYLKENTEEGDLVLTIGAGNIYEV
GEKFLEENKK
>TTE1647 MurD, UDP-N-acetylmuramoylalanine-D-glutamate ligase
MELKEKRVFVAGLGVSGVALCRVLVNLGANVIAYDRKNEIALKEALEELK
DLPVEIKLGEFKEEFLKGIELVVLSPGISLESEIVKKAKDMGLEILGEVE
LAYRLSKAPIYAITGTNGKTTTTSLLGEMFRNAGRKVYVAGNIGYPLIYA
ALEAGPNDHIVAEISSFQLETVKEFRPKISCIINITPDHLDRHKTFENYA
NIKGRIFENQREEEYVVLNYDDPVTWGLKERAKAKVFPFSRKKVLENGAY
VKEGFLYLQNKKVIKVEDIYIPGEHNLENALAASSVAYLSGIEVDAIETT
LRTFKGVEHRIEFVAEIEGIKFYNDSKGTNPDASIKAIQALKTPIVLIAG
GYDKGSEFDEFVKTFDKKVRKLILIGQTAQKIKKTALKYSYPEEDIFLVD
SLEEAVRKAYEVAEKGDSVLLSPACASWDMFKNFEERGKAFKKAVMDLRR
>TTE0008 MurE, UDP-N-acetylmuramyl tripeptide synthase
MKGLGVAIGKLVNISCKITGKGGTSLPGKIALMADDHLIKKLIEPLKENK
VIVTGTNGKTTTSGLIAHLLSYSGRKVVHNREGANMRTGIATSLIKSSSL
TGNLDRDAAVFEVDEANLSFVVNEINPNVVVITNFFRDQLDRFGELDLIV
NKVKKALSDLSKDSFVLLNADDPFTASIGEDLEAKVLYYGIEDDIKSLKS
SSFEQKFCPVCGTKYEYKKIYYGHLGNYYCPNCGKKRPSLDFRASDIFLS
EDGIKFKLSYKDKIFTVKSNLVGLYNVYNILASTSAGMLLNLDDSTILKA
VENYWPIEGRLQKIQIRGKKAIINLIKNPVGFESTLNMLSQFDKPLNLLI
LINDNYADGRDVSWLWDVNLEEFLSKAKVNHIITSGLRAEDMALRVKYAG
FDTERIKIMPLNEAVKEILDITKEELIAILPNYTALQDLNKYLKSQGALK
>TTE1649 MurE2, UDP-N-acetylmuramyl tripeptide synthase
MVSIGARRPIMRLVDLLKGVKHEIKGNPNVDISGVCYDSRKAKPKYLFIA
IKGFKTDGLLYVEEAIKNGAVAVVTDRDISEYPGVTVVLVEDARAAMAKI
ASNFYNNPTSKLTLIGITGTNGKTSVTYMLKAILEQQNNKVGLVGTIQNM
IGDRVIPTTHTTPESLDLQELFSLMVNEGVKYVVMEVSSHSLALHRVDSC
DFDIAVFTNLSQDHLDFHESMEEYAKTKSKLFKMAKKASVINIDDKYSSM
MIESSKGKVLTYGIKDFAYVMAKEIKNSLSGVKFKVQIQDKKEEISLKIP
GLFSVYNALAAITVADFLGIPLRSVREALSHVTVKGRFEPVETGRDFYVF
IDYAHTPDGIRNIMEALKEYEAGRKILVFGAGGDRDKSKRPLMGEVAGKY
ADFCILTSDNPRSENPKEIIAQIEEGIKKTNCPYVVIEDRREAIRYALSN
AQKDDVIILAGKGHETYQIIGDKVIPFDEREIVKEILAESEK
>TTE2785 MurE3, UDP-N-acetylmuramyl tripeptide synthase
MKIKEIRVYRGRNVYSHRPVIKMTVDIEGEEIPTKDIPGFNETLLNLLPG
LKKHTCSYGYEGGFAKRLEEGTYLPHVTEHIILELQNVLGYDVKFGRARN
VEGSLYNVIFEYSLEECGIRAAKLAVDLVNKLIRGEKIDLEEKLEKISNI
IAEVELGPSTMAIKMEALKRGIPVTRVGNGSILRLGYGKYQKIIEGTISQ
NTSCIAVDIASDKILTKKILKDHGLPVPEGDVAYNEEEAISIAEELGYPV
VIKPYNGNQGKGVHLNISNREEVVIAYRNAKNYSDLVMVEKQIRGRHYRV
LVVGEKVVAVAERIPAHVIGDGVHTVKELIEIENKNPLRGNGHEKPLTKI
TVDAVSKMVLQKQGLTLDDVPRKGRKVFLRESANLSTGGIAIDRTDEIHP
HNIEIAVRAAKAIGLDIAGIDITMEDIRKPLSATNGAIIEINASPGIRMH
HYPSKGKPRNVAKAIVDMLFPKGSKATIPIVSITGTNGKTTVTRMVAHIL
KTYGYTVGMTTTDGIYIDDKCIYKGDNTGPKSARTCLADKNIDAAVLETA
RGGILREGLGYDLADVGVITNISEDHLGIDGINTLEDLAFVKALVVEAVK
DDGYSVLNADDPMTPYLAKKAKGKIIYFSMYDNNLTVKRHIENGGIAVYV
KEGVIVIANGQIVPVVRIEEIPATLGGKVLHNIENSLAAIAASYGVKVPI
NIIAKGIKTFYPDTTHNPGRFNLFNIGSFRVLVDYGHNVEGIKKVIEAAR
KLDANRLIGVIGVPGDRMDSSIFKVGEVCGGGFDFIYIKEDEDLRGRKQG
EVAKILEEGAIKGGMDKKNIKIILKETEALKAAMHSAEAGDLIVVFYEKY
EPLVKVIEEFVKNRQIKNMEDENKVRAYP
>TTE2546 MurF, UDP-N-acetylmuramyl pentapeptide synthase
MAQLEGYKIKNFFKWHFRNYDRWVKESLLALLSAGIAFIMNIFRLPSEII
ILVPIALFFYITYKEVTTKKKAKKPLVFTARATRLFLTFWLLIALSFYFL
KKNFQAPEVFSAEVLILTALLPVYMALSLVITFPLEKFIQFLYYKSAQRK
IRNRKDLITIGITGSYGKTSTKHFITAVLSEKFSVLMTPESYNTPMGVTK
VIRNELKDTHQIFVCEMGARQRGDIKVLVKLANPKIGVITSIGPQHLETF
GTIENVAKTKFELVEGLPEDGIAVLNGDNYYCRTFGEKFAVRKLFYGTES
PIERKYFLWAENIINTRQGLKFDAVTEDGMRIKCEVPLLGRHNVSNLLAA
ISVALALGLNEEEIKRGLSRIEPVPHRLQLISTPHGVTVIDDAFNSNPEG
AKEALACLKEMDAKRRIIVTPGMVELGEKEYEENKNLGKNIAEVCDYAIL
VGKKRSRPIFEGLKEASFPEEKVFVVANLDEATKVLQTLLQPGDVVLFEN
DLPDNYEG
>TTE1645 MurG, UDP-N-acetylglucosamine:LPS N-acetylglucosamine transferase
MRYLFAGGGTGGHIYPAVAIAKEILKNEQDAQILFVGTEKGLEKELVPRE
GFELVTIEVQGFKRKLSFDTLKTVYKAFTGFKQANKILKDFKPHVVIGTG
GYVCGPVLMAAVIKRIPTLIHEQNAFPGLTNRLLSPFVDIVAVSFEDSVK
YFKKAKKVVVTGNPIREELLRVKKEEGREKLGFSMSKPLVVSVGGSRGAE
KINSTMVELLKIKDRKFQVLIITGSSNYDKVLEKVKKENVVLDDSVKIVP
YSHEMQYVYAAADIMICRAGAITLSEITAVGVPSILIPSPYVANNHQEYN
ARLLERQGAFHVILEKDLDAKKLYEKIEYLLSEPSLLNEMREKAKSMSRT
DASYKIYQLVKTIT
>TTE0209 MurI, Glutamate racemase
MDKNGPIGIIDSGVGGITVLKRLLEILPEEDYIYFGDTLRVPYGNRPKEE
IEKFTREIVNYLKKQKVKAVVIACNTICSSINKNDYEILMFGILEAGIKS
AVEATSNGRIGVIATKRTVESEAYLKGIKRLNRNAMVFQKACPELVLIVE
NGFYEASSIYSAVKKCTEEFLEKDIDTLVLGCTHFPILLPFIERVVDNKV
TVVDPAIKLAHEVKKYLVENNLVKDKKGGQIRFLVTGEKENFIKVAGTFL
NDKHIDVLRIAIEELK
>TTE0595 MurI2, Glutamate racemase
MDSRPIGVFDSGVGGLTVLKRLIQVLPEEDYIYFGDTKRVPYGDRSKEEI
ELFAGQIINFMKEKNVKAVVIACNTTCATIDKGKYDIELFDVLKAGAESG
VYCTKNKKVGVIATKRTVESRSYEINIKSINPQIEVYQKACPEFVPLIEK
GLYNSHLAYKAAKDCLEEFKGKEIDTLILGCTHYPLMEPIIKAIMGDGVK
VVDPAVRLSHEVKEYLERSRILNFGKKGKIEFFVSGDAENFKRAAEMVLG
KKIDEVFIVDIERY
>TTE1225 MurI3, Glutamate racemase
MWGDKMRYFPIGVFDSGVGGLTVLKRLMEVLPQENYVYFGDTRRVPYGDR
SKEEIKAFTKQIMNFLKKKNVKIFVIACNTISAVFEKEGKEIVFNVVEAG
VKSAVETTCNKRIGVIGTRRTTEERIYSNKIKEINKSIEVYEVACPELVP
LIEKGFYKTESVKRVVIECVKNLKEEKIDTLVLGCTHYPIVIDYIEEALI
GENVRIVDPAERLAYDVKEYITRVNMINPNGSGQVQFYLSKMTQSFIEIA
KILLEGKINNYNVSIVDITKY
>TTE0841 NlpD2, Membrane proteins related to metalloendopeptidases
MAKKRQKYINIMVIPDSNRQIKTIKLSIPLLKAVSTVAVALILTATISLV
YFSKTTAHLYTVILEKDMQISQLTQIKEEQDRKIAALNKNAQMVNEKIKN
LTELEEKIRRMVGLASPTTSRGNVTRTLPSDSTISYDNQTTTELLSEIDQ
KTEDFKDLISKVEARLNYLAALPSAYPVYGTITSPFGMRKNPFGYGYEFH
PGIDISVHIGTPVKAAGKGVVVYAGWLAGYGKAVIIDHGYGIESVYGHNS
QILVKVGQTVNRGDVIAKSGNTGRSTGPHVHFEIRANGSPVNPMKYLAKG
N
>TTE0907 NlpD3, Membrane proteins related to metalloendopeptidases
MKYYYSKKINHYRKYIDLFENQLIIAMVLLGMVLLFKAIDVPLANSFINV
TKSVLTYNMDYENTKKGLKLVQSKIPWLKENVVKVFSQAEEKPFSKEAIQ
TSSKMMAPVEGRITSGFGERVDPFTNKVTKHTGIDIEVPVGTEVKAALDG
VVMLATEKEDLGKVVVLRHEGDVRTVYAHLSEIFVKEGQQIRQGEVIGKS
GDTGKVTAPHLHFEVWENGKPIDPLTKVVINEAASEERK
>TTE2092 NlpD5, Membrane proteins related to metalloendopeptidases
MIVLGEYLKNYLKRAAKRRILHFLVRNPYFWMVAGFLILISFGVIITLGI
FGAAYGDDTISANTQTAKNIVSSLNPPVISSDKMEEQFFLPWAVPYALQL
YARDWDDTLDKDMVANITKDLNPVFTYFDYDEVTQVWESVKDKDGNWQTK
YYEIRTPRKYISQVNTYAGIYVIHYKEFTSENFTKGTDYSKHTITHYIAK
TGIDFYPDWTRLDAAITKYAYVNTTTNNFNVQEFPVKGGKIIKPFDGNYP
VTSPFGMRENPENPGSREFHPGIDFGLPSGTPVKAAADGVVVLAGEYGGY
GKAVIIKHTDGLSTVYGHLSEIKVGEGKEVKQGEVIGLSGNTGRSTGSHL
HFEIRKDSQPVDPLQYLSGTLVLSDGTVYYVSEIDRKMLLETAASFMENK
ESIDWLLDSSDYSMGEGVPPWQKYDVKPGEIPNELIPVFKTAGEKYGIPW
TVLAAVAYRESSFNPNAVGPYLPDYNTSAVGMMQFLPETFSEYGVDGNGD
GIISPFDPSDAVYTAAHYLSANYNLYKKKGYSDIDALRKAVWHYNHAWWY
VDQVMSIAEKYKERYIDNINK
>TTE2691 NlpD6, Membrane proteins related to metalloendopeptidases
MGKVGSESYKFLLFLKEYQKNLIAFLFALFLGLAFVVYENGFAYNVLVDG
VSIGVTRDVEGVKRVVEEIKKEEMQKWGDVVFDQEISFERIRVSGERVKD
AREIEASLKKILSLTCKAYAIEVNGKPVAFLKSKEEAYKTLEDLKSEYKK
DADKIYFKEEIKIKSKYISPTKLVEEKEALEILRKPLKEAVTYEVKENDS
LWSIAREHDMYIQDILKLNPGLTENLKPGQIIYLSKEVPLVTVVTEKEVT
YKEEIPFNTKFTKDDKLFVNQSKVLVEGEKGLKEIKAVVISHNGVEVKRD
IKEERVLKEPISKIVAVGSRRVSYVATGYFSYPARGTITSRFGPRWGGFH
TGVDIAARYGSPIYASDGGTVIFAGWESGYGYLVKIDHHNGYVTYYGHAS
KLLVKVGDKVEKGQKIALVGATGHATGPHVHFEVRKNGVPIDPMRFLGR
>TTE0644 NrfG, TPR-repeat-containing proteins
MAQKPVAKKSKTKSKTGQMPKISGKLDIVFYIILLILVFYPPFFRGMFFE
KEMFPTIAITSVVFILWAVYKIAVKEPIIATTLDYAALSLVGAYVISTFF
AVNVRASIGEVLRYCDYLFIYFMVSKLVKDNKKIFMLLNVLVLSSFFVAV
IGLGSSVNLIHYNGSWVGGRINSTFQYPNTAASFLMAFFLVNLALISYTD
NRYLKALYGAIAYTQFYAYVFTLSRGAWLMLPFLGLLLMALMPKGKRVEP
FMYFIGVIIASALPIAKFNSAVASGDAMRLVKWYLIGFLSSLVITYAISF
VMGFVNKISAKIALAIASVLIVLVAIGGYIVFTTQVPLTLKHTADEPDGM
KAVTRFVNVDPDRVYVLKYDVIAKNPENKDWAYGIVINSRNENDQSTKIA
EVYEKGDFIGEKTLEFTTLKDTKSIAIVFMNNFKDTSATFTEAKVYPKND
PKDVQTVMLKYKYLPEDIASRVQDINLTSRSSSQRMQFYIDGLKIFKDYP
IFGAGGGAWAALYFKYQSYLYWTTQTHNYFMQVLLDTGIVGFIALLFLLV
TLIRSMARVYRGYGEDKYKVLIAGVITAIVSLYAHAAMDFDFSLSAVSIA
LWALIGVINSLDREILKVKSRKVYLNYAAVLVTFVVLYMSTSMSVALGYA
VKGDNFLKSQDLNSAEAAYEKAVAYDPFNAQYRMTYGQILAALGDKWQDP
VRLQKAMFEEEKAVKLEPFNSRLNAQLGAFYLAHGQIDLGLKYVEKAVEV
QPFRPENYQQLADAYNKVGMYYLNKGDKQKAKEYLQKAVDVEKMYEKVNA
RSLEPKPMTEATKQIIEESKKALQGIQ
>TTE2703 PgsA3, putative enzyme of poly-gamma-glutamate biosynthesis (capsule formation)
MGKRIFIKALLFFFAVVFVMVFFENSVDNSAMRKVTVEKEESLLPVKEGQ
DTKDAEKVLDYTEIVVNAVGDCTLGSDEKYSKYGTFDEELKKQNYDYSYF
FRNVKDTFKKGDLTIANLEGPLTTSTKRAEKEYAFKGHPSYAKILKEGGV
DAVNLANNHSFDYGKEGFYETVNALKKEGIGYFGYGYRYITEVKGVKIGV
LGYTGYDDTEWTKQEIKKDIEKLRPEVNILIVSFHWGEESKYYPNKIQRN
LGHFAIDEGADLVIGHHPHVLQGIEKYKARYIAYSLGNFVFGGNRNPKDK
DSMIFQQIFFVDKEGKVAETKANIIPVSISSQKDRNDYSPRLLEGEEREK
VLEKIEKLSQWDKITLE
>TTE1974 Prc, Periplasmic protease
MSKKRFYVLLAVLLIVTNVFTFFIANTVSVALPGGKVIVSREDYRLLNQY
KKLFEVGKILESRYVDKVNPSTLLEGALKGMAGSLQDPYTVYMNKKEFAE
FMTQTTGTYGGIGIIVAVDQEDHIVVVSPIKNTPGERAGIKSGDIILEVN
GKKVSGKNLDEAVSMMRGPKGTQVTLTIMRDGKTFTKTITREIIKLETVF
DYMLPDKIGYIKITLFDQSTSSDFKKALERLKKDGMKGLIIDLRDNPGGL
LEECVNIADMLLPKGVIVTTKGRAESQEFYSKGTGLGMPLVVLVNKGSAS
ASEILAGAIKDRKAGVLVGTTTFGKGLVQTVVNFGDGTGLKYTIARYYTP
NGTDIQGKGIEPNYVVELPKDYTLKDTPDLKGDTQLIKAYEIIKSEIK
>TTE2356 Prc2, Periplasmic protease
MFRKRIIKIVLAVIMVIGAAFFLSYMIFYNPSYSYSEVYNKYYKNLKDID
LAKGLTAEQKLEDFEYLYNTLQKNFPFFEMGKRKTGFDWLSHKEEFEKRI
RETKNNVEFYNEIKRMVTLLQVAHARLVSPELFEKFQKAFNEVVKSEEKQ
LDPLTNSIIIKNYEYWKQTIKETTYILPIVFSYIEGKYVAIPYNKNESLE
EYGVPEGSILLKVNELAADEYAKSLMDKAFLNYDFKRNKIVKYKLYVFAD
SLEDTIKLTFLSPKGEEIEKTLQPIEVKINQSMLDNKLPLVKGMLVKGKV
AYLKIPEMKMSQNDIKKDGKEIYSFFKEIKDYPYLIIDIRGNGGGNVMYW
IENIVKPLTDKKIAYKAYTVVKNYDIKYTKTLDKLPKGKNYPPELKDDFG
YFAEISYTVTPKNYVGFKGKIYLLTDAGVYSAAEGFASFAKATKWATVVG
TPTSGGLGFNPDLLVLPNSGLIIRYPNNMALNPDGTANEEVGTQPDIYVE
ESYDDFVNYLKDREKIDENNILDMVKYDTVLKRILEMVR
>TTE2617 Prc3, Periplasmic protease
MRKFSIRIFTLLLVFFLAFTSYTYAEVSTQDQDLYNELADIGAIMKYITD
NYIDNVTYEQLKEAALKGIFSSLDEYSTYFTKEEFSQFERGTSGTFSGTG
MVLIEKDGKIVVDSVIEDSPAAKAGVKSGYIIKTVDGKSVEGMKLTDVVN
MILGDPGTKVKITFDVGGTLKEIELVRQVIHINPVSYKLLEEGIGYIKIT
EFNENTTANLTKALLFMDKNNVKKLILDLRNNPGGLLTEVVSAANFFVPQ
GIVVTIERRNGEKEDYYSYLTKPKYKLAVLVNKGTASAAEILAGAIQDTK
VGFLVGENTYGKGTVQSVVPLEDGSGFKLTIARYKLPSGRYIGKEGLTPD
VYVKNVQYTADIKFGGELKIGSRGNEVKILQKYLNLLKFNAGPEDGIFGP
KTANAVKELQKKAGLSPTGVFDKNTYNALLKMIDSLNNKDAVLEKALELL
RNM
>TTE1724 RacX, Aspartate racemase
MGKKRKIVGILGGLGPMATVDLFRRIVEFTPAKVDQEHLRIIIDCNPQIP
DRTKAILYGGPDPTPELIATAKNLVKAGADFIVIPCNTAHYFLDYLKREV
DIPIINMIEETARYVRNNYPYAECVGLLATSGTIKSNLYHKAFKKFGISV
LAGDEKKTMEAIYGEEGIKAGNLGEKPRRLLKEAAQELIRRGAQVIIAGC
TEISLVLGEEDVSLPLVDPLTILAKVAVELALGI
>TTE0768 RfaE, ADP-heptose synthase, bifunctional sugar kinase/adenylyltransferase
MYEVVKDIGEERVTELLHRLRKGKIAVIGDVALDIYWRADMRKSELSRET
PHFPLPIVEEWMSPGAAGNVATNIAALKPEKLFLLSIIGKDWRGDLFIKE
VEKRGIITDFLIRSDERVTNAYCKPLKRGFSDVEYEDPRIDFENFRLITQ
KEEDELIKLLEKVAKEIDVLCVVDQMRFGCITPRVREKIENFSREGLTVI
VDSRERIGYFTDVILKPNDIEMFKAMGIEKDPQKLSIEELLEFAEKFSIQ
KRSDVCVTLGARGAIYVEKDTSKKYYVPTVNLTPPLDVCGAGDTFLSIFS
LVLGTGGKKVEAVFMGNLAASVVVKKIGTTGVATVEEIMDNYKKHWATS
>TTE0066 RfaG, predicted glycosyltransferases
MSILGRNIAFLSTYPPRECGIATFTQDLVNEIKKIKLINFAGVIAINDHK
RYDYDEDVIYEINQFEREDYLKLAEKLNESNVDLLIIEHEYGIFGGESGE
YLLDLVDNLSIPFAVTVHTVLLNPNEKQLKILKELGQKSARVITMAKNTI
PLLEKIYEIPSHKITFIPHGVPTLPVLPKETLKERYGFKGRRIISTFGLI
NPGKGIEYGIEAISMVAKKYKDVLYLILGQTHPNIKRLYGEEYREKLQKM
VKDLGVEDNVRFVDKYLTKREILEYLKMSDIYMTPYLNKEQAVSGTLAYA
AGLGKIIISTPYMYAEEILGNGRGLLADFRSAKSLAEKIEYVFEHPEARA
RMESEMKKLGSTMTWNNVAYRYVIMILSVLDVKSREEVVI
>TTE0275 RfaG2, predicted glycosyltransferases
MKSSKNRRKWGLAMDNLKVTVFTNEYPPNIYGGAGVHVDYLTRELSKLMK
VDVRCFGDQKFFSENLTVKGYKEWEELKEGLDPRYQKVLGPFSIDLAMVK
DPVDSDVLHCHTWYTFMAGFLAKKLYDKPLVVTIHSLEPLRPWKEEQLGN
GYKLSSWMEKTGIKAADRIIAVSQGSKEDILKYYDVPEEKIEVIYNGIDL
KEYKKIDRNVARKKYGIEGRYILFVGRISRQKGITHLIDAVKYLPKDVKV
VLCASSPDTPEVLEEVEQKVKLHDNIIWINKMVEKEDIVELYSNAEVFVC
PSIYEPFGIINLEAMACETPVVASATGGIKEVVVHEETGFLVEPGNSEEL
AKYINILLENRELAKKFGINGRKRVEEMFSWGSIAKKTYEMYRKVVQEYK
KAKK
>TTE0500 RfaG3, predicted glycosyltransferases
MPTSWYNVIPEILSLIEKHKPRSILDVGIGFGKYGVLIREVLELPYERYD
KLKWQHRVEGVEVFEGYKNPLHTYAYDKVYYSNILDVIDKLPQYDVILLI
DVLEHFTKEEGYLLLDKLLEHTKNFILISTPLYPDIQKDYEGNPHEEHKS
RWSIIDFVDYDYSFKLIPIGNNGAQLFTIFPTAQGVKEKINTHLYTQIIE
NNSLNAKPKLKIGYLLPHKNLTGGLKMLLENMRYMKKRGHTICGFLKSDT
NDDVIPNWYRDIEIDEKIILPHKDSFSYYIEDCDIVIAGWLGQLIELKRN
KIHVIYWEQGSEWLFGDYRDLSPNSKIREHLKECFSSDVTFVSASPLIAK
VLKVRYGKDSTIIPNGIDTTFYFPRKKEKSSQDISILLVGHPYLWFKGFE
VALIALEMVWRKGYRFNVNWVCQELPNVKNLSYPINFIKKPSQEELAEIY
RNSDMLVFTSWYEGFGMPPLEAMASGIPVISTRCGGVESFITPGVNGILV
EPGDIEGIAYAVMELIKNSKLREILAKRGRQTALNFDFEKITEMWETVLY
KVKGDA
>TTE0655 RfaG4, predicted glycosyltransferases
MRDNRIQDVALISSYNPYITNLGGLQIHLLLLEKGLRLNNVNVVTKYYTF
SSFEKAKLVFRYPFYKFMSYKDRVITRTKLIEKFFKKQHFEIFQVVNAHD
VISGAFCNSKKIVLTLHGYYTREAINYGGFSKEDIPDFERFGRDLEKRAI
DKAQRIITVDSRIKEYVVSEFSFPKEKVDVIFNAVDIDIFKPISELEKKQ
IREELGWGEEDFVVFIPRRYVKKNGVIYAAKAANILKEKDIKFIFAGIGP
LKEEILNITHKNKNVKVLEGIPHDEIVKYYKACDVVLIPSITSDGVEEAT
SLSMLEGMSCGKIVVCTPIGGMKEIIKHGVNGFFVEQKSEEAIAYIIEKI
KEDFYKLDSIRQEARKYIEKNHSYIVHARKFIEVYEKAIK
>TTE0658 RfaG5, predicted glycosyltransferases
MNRIKVLQIIPNFGYGGAERLTVNLMKYLDKEKYEVRAISMFDSLNTELE
KILENENIPVYYLGKKKGFDPRMFFRIDKIIKSFKPHIVHTHRYVLRYAL
PSLLLHKVPVKVHTVHNIAEKEVDKVGKLVHKIAFSFGVIPISISRLVSE
SLTSVYGVKNIPLILNGIPVEYYQKANINREEWREKEGFQKEDFLFVNIA
RLAPQKNQALLIEAFAKGPARHDNSKLIIVGDGEERERLEEITKLHRLEE
KVYFLGIRTDIPDILNASDVFVLSSDWEGNPLSVMEAMAAGKPVIATSVG
GVPELIQNNITGILVPPKNVNAFSKAMLMLIENKDLCQKLGEKAKEVAEK
EFDISVMVKKYEKLYESLLQFKLKKGASLL
>TTE0660 RfaG6, predicted glycosyltransferases
MKGMKIAYITSQTPYGKGEQFILPEILEVIKKGHDVVVIPVRPEKEIALG
DEPKEVAKFTMHIPLLSLNLILKSFLIFIKHPLRVVEIIFKILRHSGSLG
KILKNLLIIPKGLVVSEILKKRKINHIHAHWASTPSTLAYIASELTGIPW
SFTAHRWDIAENNMLREKARSSNFIRVIDKNGYDEILSYVKEYRDKLYIL
HVGVKVDVNFKKLDLKKANRALLIAVPANFVVKKGHIYLIQAIKKVIETQ
NCNVYCYFFGKGLLEDELKLTVTQLNLEDRIFFKGQLPHDELIELYRSGK
IDCVILPSIVTDDGEKEGIPVSLMEAMAHKIPVISTNTGGIPELLEGGAG
IIVEQKNSDELAKAIMKLINDEKLREELGEKGFEKIEKEFNLSKIVEELL
YLMGNN
>TTE0662 RfaG7, predicted glycosyltransferases
MSGKNIWILNHYAISPDMAGGTRHYDFGKELVKKGFTVTIFASGFDHVTK
KHLKVSAKESVREEVFDGVRFVWLNTFPYTKNDWRRVVNMISYAFRVIKV
AKKFEKPDIIIGSSMHFFAPLAGWWLSRKYKARFIFEVRDLWPQTAIDMG
AIKENSILAKLLYIWEKFMYERAEKIIVLLPDAKSYIAKRGMPEQKIVWI
PNGVNIERFETDISIDENLEVFEVFKKYKDKFKVVYAGAHGPANGLEVVI
ETAELLRDYEDIQFILIGDGVGKESLIEMANKKKLTNIVFLSPISKKFIP
TVLRKADLLLHSLKHMDVFKYGISPNKIFDYLASGRPIISNVSASKEIIE
EANAGIIVPPENPKLLAEGILKIKNLSEKERNQMGLNGRKYVEQHYDIKK
LTEKLIKELEL
>TTE0949 RfaG8, predicted glycosyltransferases
MVFMDKRRVLYIVRKSEGGMKRHLLSLLRFLDKEKYCLGVVCSFEKDTID
YLKNQGIEVFELEIGDGFNVKEDLSIIKKIRNIVKEFKADIVHMHGFKAS
FVGRIACFNLPVKTIVTFHNFPGYNNMSEMKRRALLFLIKFLNKRTDQFI
AVSEALKKEMMASERIEEDRIEVIYNCIDETLYKMGELDLRKEFNLPEDS
FIVGSIARLIPSKGVQDLIEAAHLIKEADVFFFVAGDGPYRKSLEEKIKE
KGLESRFFLLGFRDDIPSFLRNLDVFVLPSHEEGFGISVIEAMNEGVPVV
ATAVGGIPEIIQEGVNGILVEKGNIESLSKAIKSLLKDAHLKETLSLKGK
EAAKKFSCEEMVKRVEELYERIKG
>TTE0154 Rfe, UDP-N-acetylmuramyl pentapeptide phosphotransferase/UDP-N-acetylglucosamine-1-phosphate transferase
MKIYFLSFILAFAMSFVTTPLVKKLAFAIGAIDVPDDKRRIHTKPIPRLG
GLAIFAGTMASLLLLLPKSHETIGIILGSLVIVLLGVLDDKYTLSAKVKL
VGQIAAALILILSGIRIDWISNPFGSGVIYLKSWVAISLTLLWVVGVTNT
INLIDGLDGLAAGIAFISSTSLFIISLLNGRYATAVISIAIAGASLGFLP
YNFNPAKIFMGDTGAMFLGFLLSAISIQGAIKSATAIAIVVPVLVLGVPI
FDTLFAIIRRILNKRPIMEADRGHLHHRLLDKGLNQKQVVFILYGVSLVL
GVSAILISFVSELKSLVILAVSLLFILWGANKIELLRSNKKGTQTR
>TTE1648 Rfe2, UDP-N-acetylmuramyl pentapeptide phosphotransferase/UDP-N-acetylglucosamine-1-phosphate transferase
MIQKIIFATLLSFTVAIISGRFFIPYLRKLKFGQKVREDGPKTHLKKSGT
PTMGGIIFVVATFLTSLIFSPWNKYLFILLAGFLGYGLIGFADDFLKVYF
KRSLGLRAREKLLAQFLLAIVISWFIKSNVGTEIIVPFFKRSVDLANFYI
PFAVFIIVGTVNSVNLTDGLDGLAAGVSTIVMAFFAMIALFLNDVTYGVF
SASLTGGLLGFLRYNKHPAEVFMGDTGSLAIGGAVATVALLTKLPLILPV
LGIIYVAEAISVILQVFSFKLFGKRIFKMSPLHHHFELSGWKEEKVVYSF
WLVTLIALFVSFYSLS
>TTE1126 SpoIID2, sporulation protein and related proteins
MEKKKVAVFLLSSSLVLSMANNAYAATILKYGMRSPEVRKLQENLNRLGY
FVTSTPTDYFGPATLNALIKFQKDSNLVPDGIYGPSTEKVLLEKLNAFSG
KNVSSPPQTSNTSNSSATQTVAQATFSRTLRYGMQGEDVKFLQSILNKLG
FDVGTPDGIFGFKTQNAVVQFQKANGLLADGIVGPATQKVLLQKVNAPSP
SRGDEKREEVQTTLPSSSNGSGKGISNGDGNAIFNKVLKYGMIGEEVKLL
QQYLNKLGFDAGVPDGIFGGKTRQAVINFQKSANLEADGIVGPMTWQALI
SRLNVTLPSRGDVNRDNPQNQKEDQIQFPTPFTRELKGGLQGDDVKLLQG
MLSELKYYDGDVTGTYDDVTSNAVRSFQQYYSLNPTGIADVDTLKKLLEV
DAQVKAVKGFYVQGKGGYGHGVGMTQFGAKGMAEQGFKYDEIIKYYYTGV
DINKVDTSNVNVKVKISLDVTSQDIKITSSQPYNVIYKVKDDSTGQIIEK
QETFLPDSVTSINYLDGNILIANSQSPEIRTSVDMVKIVPTNDGVLFYVN
KARPYEGEFRIYPNPNSIPSGLDLINVLPIEEYLRGVVPAEMSPSWPEEA
LKAQILAARTYALVRIKDENIFDVYDTTLSQVYKGISIADPKIDQLIEST
KGEVVTYGGKLADTVYSASAGGYTVDSFFAWKKDVPYLKGKPDPYDTSKY
ATYWWNVSISRSQIEKAYPQIGAVLNVEITKKMFDRPVEIKITGTKGIIT
VGNDDFRKAIEDAAGQKLFASEYFDIVIQN
>TTE2058 SpoVG, uncharacterized protein, involved in the regulation of septum location
MKVTKTTFKKYESGRLKGFARVVFDDSFAIVTRVIQSKNGLIVALPDHVN
KEGRRSLVAFPLTRELRQEIVESVIKAYKEAE
>TTE2573 SpoVG2, uncharacterized protein, involved in the regulation of septum location
MKITDVRVRKLNDEGRMKAVVSVTFDNEFVVHDIKVIEGQNGLFIAMPSR
KTPEGEFKDIAHPINSDTRNKLQKAILEEYEKAKENNSNKE
>TTE0880 Spr, Cell wall-associated hydrolases (invasion-associated proteins)
MESKIGKIIFGVSVFGMTLIGNSFLHPVFAEGLGVGKVTGNYVNVRTEGS
LSGSVITQVSKDEVVTVLEKQGDWYRIRLSDGREGWIYGEYLSVRSSNGV
SRGDTGEVSVGVVTGNYVNLRSEGSLSGKVLMQLSKGTQVEVLDRQNGWY
KVKLSNGQEGWIYREYLSVRSGVYASRGEVDRSLVDKLIDFAKSFLGTRY
VYGGSSPKGFDCSGFVSYVFSNFGFSLPRTADEQANVGDTVTRDSLEKGD
LVFFRTLGSSIINHVGIYIGDGQFIHASSGAGKVIISPLNEGYYLSHYVK
AKRVIK
>TTE0501 WcaA, Glycosyltransferases involved in cell wall biogenesis
MDLKDQFKMLYKEISPSTLSLCLITKNEEKNISRCINSVKDIVDEIVVVD
TGSTDRTIEIAKSFGAKVIQIKWEDDFSKARNTAIESATGDWILFLDADE
EIKKEDVSKIKSLLYDDTVEAYLFKFVNYAGSSINSGLTEINYNYRLFRN
NGKLKYIYPVHENLRNIEENRPPIAKKADVTILHYGYLADIRKEKNKSER
YIKLISKYLESHPEDKFQHANLAVEYFNIGDYQKALKHLLIATKGMDVNS
VNATRLLRYLIGCYIGLKDYSTALKIIKDAKDYYKDIPDFSFLEGLMYMD
QKRYEKAIEAFKESLSIGEYDGLFITMGGTGSYRARYMIGLCKEKLNQLN
DAVKEYIEVLKENPNYQEVFIKLFDLFIKNEPVQEVYKFFSKYVDVSSPL
NNAILARLYISVGLYDAAKSYLDNINMDLEGLNTLRGIVYMGMKKYEEAL
QYFGNEYGKSQEEANYYKVLCHIILNQMEEAKKVLWELPDSSDKKLYMSI
VGEMKAKFEEIKENYFNLLDLLIKLQEFDLYNKVLAMYVNKFGREDYERY
GQLMIKYELEDLAVEAYIKAANLNSQNPEVYRYLAEKALKQGMYEEALSL
AMNAFNLDTMDVDNYVTIYKIYRDMGNLNEAEKINLVVKEIYPEIDLASR
VNGG
>TTE1307 WcaA2, Glycosyltransferases involved in cell wall biogenesis
MMNKKVSVLIPAYNEQDKIIDTIKGLEVVKEVDEVIVINDGSTDQTAERA
KKAGAKLVNMKENMGKAAALREGLKYAKNDIVVFLDADVGLTSREVEKLI
KPVFLDEADVVIAKFPKTPVKGGFGLVKSLARKGVKYFTGKEIESVLSGQ
RAFKREVLESLDTFYKGFGIEVGMTIDILQKGYRVKEVEVNMTHSFTGRN
LKGFLHRGRQFWDILKVLLYKFFKSRWKK
>TTE1399 WcaA3, Glycosyltransferases involved in cell wall biogenesis
MISVIVPAYNEGKNIGRVLSVLEKIDVIDEIIVVNDGSTDNTEEEAKKYK
VKVINLEKNQGKGKALKEGVLNAKGDIIVMLDADLIGFTEKHFYSLVMPV
VKDEADMTVGIFSGGRKSTDLAQKIAPFLSGQRAIKKKFLEDIKEMEISK
FGVEVALNRYAKKNNLRVVTVPLENMTHVMKEEKLGFVKGFAARMKMYFE
ILRMWV
>TTE0665 WcaJ, Sugar transferases involved in lipopolysaccharide synthesis
MKLIIKRLIDIFVSLFLLIILSPFLVIISLIVFVAMGPPVIYKQTRAGFK
GKPFTIYKFRTMTNEKDEYGNLLPDEKRLTKMGKFLRSTSLDELPELFNV
LKGDMSLVGPRPLLMEYLNYYTEEQMRRHDVKPGITGWAQVNGRNSLSWE
EKFKLDVWYVDNWSLWLDFKILFLTLIKVIKREGLSAEGYATMPKFTGSK
D
>TTE0155 WecB, UDP-N-acetylglucosamine 2-epimerase
MGIKIMAVFGTRPEAIKMAPLIKALEKEKEFDTQVAVTAQHREMLDQVLR
LFNIVPQYDLNIMRERQTLSDITTAAIDGLDRVFLKEKPNLVLVHGDTTT
TFAAALVAFYHKIKVGHVEAGLRSFNKWFPYPEEINRKLTGVLADLHFAP
TKRAKLNLLNEGVEEESIFVTGNTVIDAMSYTVKKDYTFREERLNRIDYK
NKKVIVVTAHRRENWGAPLENICNAIKDIAKSYKEEVYFIYPVHMNPVVK
NTAHKILGGFDNVLLLDPLETDEMHNLLARCYMVMTDSGGLQEEVPSLGK
PVLVLRDVTERPEAKEAGTVKLVGTDYERIFKEAKLLIEDENEYKKMANA
VNPYGDGKASVRIVGAIKYFFGLSKEKPEEYEGGG
>TTE0661 WecB2, UDP-N-acetylglucosamine 2-epimerase
MKIVTIIGTRPQFIKAATVSRKLKDFNDMKEIIVHTGQHYDDNMSDIFFK
ELEIPQPDYYLGIGSGSHGVQTAHMLEKIEDVLIKEKPDVVLIYGDTNST
LAGTLAASKLQIPVAHVEAGLRSFNRKMPEEINRIVADHVSDLLFAPTKV
AVNNLINEGIAEDRIYYVGDVMFDAAIFYGEKAGQQSKILETLDLKPKEY
ILSTIHRAYNTDIPERLKTIFNALCKIGKDITIVMPLHPRTKAALLREGL
YEKVSEKLKIIEPVGYLDMVKLEKNAKLIITDSGGVQKEAFFYKVLCVTL
REETEWVELVDLGWNYLVPPDCEKFIEESIRKVLNAPHGLDAEPYGDGKA
AEKIVKVLRKYLL
>TTE0652 WecC, UDP-N-acetyl-D-mannosaminuronate dehydrogenase
MEREKEFNSTYYELLDKIESKKAVIGVIGLGYVGLPLAVEKAKAGYKVIG
FDIQKHKVEKVNNGINYIGDILDGDLKEVVEQGRLKATNDYAFLKDVDAV
AICVPTPLDKNKQPDLSYIINSTKEIAKYLHKGMLVVLESTTYPGTTEEV
VKPILDETGLICGEDFFLAYSPERVDPGNKEYKTKNTPKVVGGVTKQCTK
IAAALYRNVLESEVFEVSSPKVAEMEKIYENTFRNINIALANEMAIICYR
MGIDVWEVIEAAKTKPYGFMAFYPGPGLGGHCIPIDPFYLAWKAREYDYH
TRLIETSGEINNYMPEFVVERISRILNRFKKPINGSTILLLGVAYKKDID
DIRESPALKIISILEKEGAVVKYNDPHVPEFKHNGKLYHSENLTDDLLSS
SDLVVITTDHTKYDYEHIVKTAKFVFDTRNATKNLKESREKIEVL
>TTE0651 WecE, predicted pyridoxal phosphate-dependent enzyme apparently involved in regulation of cell wall biogenesis
MEIELINLKRQYKNLRDEINKAIEKVLENGQYILGPEVKAFEKEIAEYLG
IRYAIGVANGTDALVLSLRALNIGPGDEVITTPFTFFATAEAVSQVGATP
VFVDIDPDTYNINPDLIEEKITKKTKAIIPVHIFGQPCDMDKIMEIAKKH
NLYVIEDACQAIGSEYKGQKVGTFGDVACFSFFPTKNLGGYGDGGMVVTN
NPEIAEKVDILRKHGSKKKYYNEEIGYNSRLDELQAAILRVKLKYLDVWN
SQRISAANKYNELLKDLSDVIKSPYKLPEVKHIYHLYCIQSEKREFLMEK
LKENGIATGIYYPVPLHLQKAYANLGYKEGDLPVAEEVCRKIFAIPMYPE
ITDEEISYISKVLHKIVNEGD
>TTE0667 WecE2, predicted pyridoxal phosphate-dependent enzyme apparently involved in regulation of cell wall biogenesis
MKVPLSRPDITQKEIDAVVEVLRSDILSIGPKIEEFERKIADYVGKKYAI
AVNSGTSALHLIVRALGIKDGDEVITTPFTFIASVNCFLFERAKPVFVDI
DPDTLNMDINKIEEKITEKTKAILTVDVFGQPMDMEKVNEIAKKYGLKVI
EDSCEALGSEYKGIKAGTLCDAGAFAFYPNKQITTAEGGVIVTDDEEIAQ
LCRSMRSQGRPITGLWLEHERLGFNYRLSELHAALGIVQLERIEEIIKRR
LEIAEKYNERLKDVKGVKIPYIAPEVNKMSWFVYVIRVDENIDRDKVMQY
LIDNGIGCRPYFTPVHLQSYIKELTGHKEGDFPITEKVARSTIALPFFNK
ITDEQIDYVVDKLKEAIKIYSR
>TTE2163 WecG, Teichoic acid biosynthesis proteins
MDKLYIFGVPIHRVTMIEAVEILKGYLKEDRIHIVATPNAEIIMMAQKDE
EYKKILNETDLNVPDGSGVVFASRVFNKPLKERVAGFDLMMEFVKWASHK
DVSIYLLGAKPEVVEKAQSNLKNLYPSLKIVGFHHGYFNEKEEENIIEDI
NKRAAQVLFVALGAPKQEKWIYKNKEKLKVKIAMGVGGSFDVIAGKAKRA
PEIYRKLGLEWLYRLIQEPWRYKRMSALPKFAFKVLLARLKGDF